Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Surveillance for Cancer Incidence and Mortality — United States, 2013

Surveillance Summaries / January 27, 2017 / 66(4);1–36


Article Metrics

Views equals page views plus PDF downloads

Views:

Citations:

Altmetric:

Metric Details

Simple D. Singh, MD1; S. Jane Henley, MSPH1; A. Blythe Ryerson, PhD1 (View author affiliations)

View suggested citation

Preface

This report provides, in tabular and graphic form, official federal statistics on cancer incidence and mortality for 2013 and trends for 1999–2013 as reported by CDC and the National Cancer Institute (NCI). Data in this report come from the United States Cancer Statistics (USCS) system (1), which includes cancer incidence data from population-based cancer registries that participate in CDC’s National Program of Cancer Registries (NPCR) and NCI’s Surveillance, Epidemiology, and End Results (SEER) program reported as of November 2015 and cancer mortality data from death certificate information reported to state vital statistics offices as of June 2015 and compiled into a national file for the entire United States by CDC’s National Center for Health Statistics (NCHS) National Vital Statistics System (NVSS).

This report presents information on new cancer cases and deaths for 2013. The number and rate of cancer cases and deaths are stratified by the primary cancer sites as reported for 2013; information is provided by demographic characteristic (e.g., sex, age, race, and ethnicity) and primary cancer site (68 selected sites among men and 72 selected sites among women). Age-adjusted cancer incidence and death rates are shown by primary site and year for the period 1999–2013. Age-adjusted cancer incidence and death rates for the most common sites are shown by race, sex, and ethnicity for 2013, the most recent diagnosis year for which incidence data are available. Maps of the United States display age-adjusted cancer incidence and death rates, presented by quartiles, for 2013. Time trends in age-adjusted cancer incidence and death rates during 1999–2013 are shown for all sites combined, colorectal, lung and bronchus, prostate, and female breast by race, sex, and ethnicity.

Background

Cancer comprises a diverse mix of diseases occurring in every part of the body and is a leading cause of death in the United States (2). More than half of cancer cases could be prevented (3). Surveillance of cancer incidence and mortality can help public health officials target areas for control efforts (4) and track progress toward meeting the national health objectives set forth in Healthy People 2020 (5). As of 2016, Healthy People 2020 objectives included reducing cancer deaths per 100,000 persons to 161.4 for all cancers, 45.5 for lung cancer, 20.7 for female breast cancer, 2.2 for cervical cancer, 14.5 for colorectal cancer, 2.3 for oropharyngeal cancer, 21.8 for prostate cancer, 2.4 for melanoma and reducing cancer incidence per 100,000 persons to 39.9 for colorectal cancer, 7.2 for cervical cancer, and 42.1 for late-stage female breast cancer (5).

Cancer is a reportable disease in every state and thus all hospitals, physicians’ offices, pathology laboratories, and other medical facilities are required to submit data on all reportable cancer diagnoses to a central cancer registry at the state or territorial level. A cancer registry is a database that contains individual records of all reportable cancer cases in a defined population and includes patient demographics, tumor characteristics (e.g., cancer site and pathology), and information about the notifying health provider or facility. Cancer control planners and others can identify variations in cancer rates by population subgroups and monitor trends over time to guide the planning and evaluation of cancer prevention and control programs and allocation of health resources.

Data Sources

Data about cancer incidence and mortality come from the official federal statistics on cancer, the USCS dataset (1). The USCS dataset includes cancer incidence data from NPCR registries in 45 states and the District of Columbia (DC) (cancer incidence data from Puerto Rico and the U.S. Pacific Island Jurisdictions were not available for this analysis) and from SEER program registries in the remaining five states (Connecticut, Hawaii, Iowa, New Mexico, and Utah) and cancer mortality data from NVSS. Incidence data included in USCS have met publication criteria.

Incidence Data

The primary source of data on cancer incidence is medical records. Staff at medical facilities such as hospitals, doctors’ offices, and pathology laboratories abstract data from patients’ medical records, enter it into the facility’s own cancer registry if it has one, and then send the data to the regional or state registry. The data then are sent to the central cancer registry in that state, district or territory. Every year the central cancer registries electronically submit incidence, demographic, and clinical data to NPCR or SEER. Both NPCR and SEER registries collect data using uniform data items and codes as documented by the North American Association of Central Cancer Registries (NAACCR). This uniformity ensures that data items collected by the two federal programs are comparable (6,7). Information on primary site and histology is coded according to the International Classification of Diseases for Oncology, Third Edition (ICD-O-3) and categorized according to the revised SEER recodes dated January 27, 2003, which define standard groupings of primary cancer sites (https://seer.cancer.gov/siterecode) (8). Beginning with 2010 diagnoses, cases were first classified by anatomic site by using ICD-O-3; cases with hematopoetic histologies were further classified by using the 2008 World Health Organization (WHO) Classification of Tumours of Haematopoietic and Lymphoid Tissues (9). Data from the NPCR registries provided in this report were reported to CDC as of November 30, 2015. Data from SEER registries were reported to NCI as of November 1, 2015.

NPCR and SEER cancer registries consider as reportable all incident cases with a behavior code of 2 (in situ, noninvasive) or 3 (malignant, primary site only) in ICD-O-3. Exceptions include in situ cancer of the cervix and all basal and squamous cell carcinomas of the skin, except for those on the skin of the genital organs (8). Beginning with 2001 diagnoses, several cancers that are coded as malignant in ICD-O-3 were not coded as malignant in ICD-O-2 (6). Additional information is provided in the USCS technical notes (https://www.cdc.gov/cancer/npcr/uscs/pdf/uscs-2013-technical-notes.pdf#nameddest=RegistriesPubCriteria#nameddest=IncidenceDataSources).

Mortality Data

Cancer mortality statistics are based on information from all death certificates filed in the 50 states and DC and processed by NVSS at NCHS (10). The cancer mortality data were compiled in accordance with WHO regulations, which specify that member nations classify and code causes of death in accordance with the current revision of the International Classification of Diseases (ICD) (11). For consistency with the data on cancer incidence, the cancer sites in mortality data were grouped according to the revised SEER recodes dated January 27, 2003 (https://seer.cancer.gov/codrecode). Data for a specific calendar year are based on records of deaths that occurred during that calendar year and received by a particular date. Data in this report include, mortality data for 2013 based on records of deaths that occurred during 2013 and received by NCHS as of June 30, 2015. Data in this report come from USCS, which includes cancer deaths during 1998–2013; cancer mortality data for 2014 are available at https://www.cdc.gov/nchs/nvss/deaths.htm. Additional information about mortality data is provided in the USCS technical notes (https://www.cdc.gov/cancer/npcr/uscs/pdf/uscs-2013-technical-notes.pdf#nameddest=RegistriesPubCriteria#nameddest=MortalityDataSources).

Population Estimates

Population denominators are annual race-specific, ethnicity-specific, and sex-specific county population estimates modified by NCI in collaboration with CDC’s NCHS from the U.S. Census intercensal (for July 1, 1999–2009) and Vintage 2014 (for July 1, 2010–2013) annual times series (12). Modifications incorporated bridged single-race estimates that are derived from the original multiple race categories in the 2000 and 2010 censuses. For most states, population estimates as of July 1 of each year were used to calculate annual incidence rates because these estimates are presumed to reflect the average population of a defined geographic area for a calendar year. However, some county population estimates were adjusted to account for populations displaced along the Gulf Coast of Louisiana, Alabama, Mississippi, and Texas in the fall of 2005 by hurricanes Katrina and Rita. The national total population estimates were not affected by these adjustments. Other specific modifications included using additional local information to accurately estimate the native Hawaiian population and deriving population estimates for newly created counties in Colorado and Alaska. The modified county-level population estimates, summed to the state and national level, were used as denominators in rate calculations. Additional details about population data are available at https://seer.cancer.gov/popdata/index.html.

Publication Criteria

Cancer incidence data are derived from state cancer registries that have high-quality cancer incidence data for individual (e.g., 2013) and combined (e.g., 1999–2013) years as demonstrated by meeting all of the following criteria on data quality for all cancer sites combined:

  • case ascertainment is ≥90% (margin of error +5%) complete,

  • ≤5% of cases are ascertained solely on the basis of a death certificate,

  • ≤3% of cases are missing information on sex,

  • ≤3% of cases are missing information on age,

  • ≤5% of cases are missing information on race, and

  • ≥97% of the registry’s records passed a set computerized edits that test the validity and logic of data components.

In this report, cancer incidence data for 2013 include data from DC and all states except Nevada, covering 99% of the US population, and data for 1999–2013 include data from all registries except Arkansas, DC, Mississippi, Nevada, South Dakota, Tennessee, and Virginia, covering 92% of the U.S. population. Additional information about USCS is available at available at https://www.cdc.gov/uscs/.

Interpreting Data

Incidence Data

Each year, state cancer registries submit cancer cases for a new diagnosis year and an updated version of the previous year’s cancer cases to CDC or NCI. Therefore, each year, when USCS data are published, updates to the previous year’s data are published, using the most recent data submission and the most recent population data. Users of cancer incidence data published by federal agencies need to be mindful of the date of data submission for data used in their analyses.

Mortality Data

Cancer mortality statistics in USCS are influenced by the accuracy of information on the death certificate. Unlike incidence data, mortality data for a calendar year are considered complete when submitted and so are not updated after the aggregate data file is released. Mortality data for the entire United States refer only to deaths that occurred within the United States; data for geographic areas are provided by the decedent’s place of residence.

Race and Ethnicity Data

Differences in rates among racial and ethnic populations should be interpreted with caution. For cancer incidence, race and ethnicity data are abstracted from medical records and grouped into categories (7). A study using SEER incidence data suggests that the quality of data on race/ethnicity in cancer registries is considered excellent for whites, blacks, and Asians/Pacific Islanders, good for Hispanics, and poor for American Indians/Alaska Natives (13). When cancer mortality is reported, race and ethnic origin are recorded separately on the death certificate by the funeral director as provided by an informant or, in the absence of an informant, on the basis of observation (14). Previous studies involving cancer mortality data demonstrate that death rates for whites and blacks generally are estimated accurately whereas death rates for Asians/Pacific Islanders, American Indians/Alaska Natives, and Hispanics are underestimated (2,15). Recent study involving evaluation of validity of race showed that classification of race and ethnicity on death certificates improved overtime for Asian/Pacific Islanders and Hispanics (now almost as good as whites and blacks), however, remained poor for American Indians/Alaska Natives (16). For this reason, incidence and mortality data provided in this report might be underestimated for American Indians/Alaska Natives groups, possibly because of misclassification of race.

Three NPCR registries (Delaware, Kansas, and Kentucky) opted not to present state-specific Asian/Pacific Islander counts and rates. Six NPCR registries (Delaware, Kentucky, Massachusetts, Pennsylvania, North Dakota, and Virginia) opted not to present state-specific Hispanic (classified by the NAACCR Hispanic Identification [NHIA] Algorithm) counts and rates (17). Cancer registries regularly link their database to the Indian Health Service patient registration dataset to reduce misclassification of race for American Indian/Alaska Native patients; in this report, 34 NPCR registries and all SEER registries linked cases diagnosed in 1999–2013. Six NPCR registries (Delaware, Illinois, Kansas, Kentucky, New Jersey, and New York) opted not to present state-specific American Indian/Alaska Native counts and rates. However, the aggregate national rates presented in this report include data for these registries, except that incidence rates by ethnicity exclude Virginia because ethnicity information was missing on 85% of cases from Virginia.

Population Coverage

The population coverage for incidence data varies by diagnosis year. Population coverage might be affected by the suppression of state incidence data if a state did not meet the publication criteria or did not submit data for that diagnosis year. In addition, state incidence data were suppressed in this report if <16 cases were reported or if the state requested that the data be suppressed. Additional information is provided by the USCS technical notes (https://www.cdc.gov/cancer/npcr/uscs/pdf/uscs-2013-technical-notes.pdf#nameddest=RegistriesPubCriteria#nameddest=CensusRegionPubCriteria). Mortality data from malignant neoplasms (i.e., cancers) as recorded in NVSS from the 50 states and DC are available in USCS, and thus 100% of the U.S. population is covered each year. However, state death data were suppressed in this report if <16 deaths were reported.

Suppression of Rates and Counts

When the numbers of cases or deaths used to compute rates are small, those rates tend to have poor reliability. Therefore, incidence and death rates and counts of <16 are not shown in tables and figures. The use of a threshold value for suppressing cells helps protect the confidentiality of patients by reducing or eliminating the risk for disclosure of their identity and helps avoid overreliance on unstable data. Additional information is provided in the USCS technical notes (https://www.cdc.gov/cancer/npcr/uscs/pdf/uscs-2013-technical-notes.pdf#nameddest=RegistriesPubCriteria#nameddest=Suppression).

Highlights

Incidence and Death Rates

In 2013, more than 1.5 million invasive cancers were diagnosed in the United States, an annual incidence rate of 439 cases per 100,000 persons (Table 1). In the same year, approximately 584,872 persons died of cancer nationally, an annual death rate of 163 deaths per 100,000 persons (Table 2). Overall and for many cancer sites, males had higher incidence (Table 1) and death rates (Table 2) than did females.

Four cancer sites accounted for 48% of all cases diagnosed in 2013, including 230,815 female breast cancers, 212,584 lung and bronchus cancers (111,907 among men and 100,677 among women), 176,450 prostate cancers, and 136,119 colon and rectum cancers (71,099 among men and 65,020 among women) (Table 1). These four sites also accounted for 47% of cancer deaths in 2013, including 156,176 lung cancer deaths, 51,813 colon and rectum cancer deaths, 40,860 female breast cancer deaths, and 27,681 prostate cancer deaths (Table 2).

By state, overall (all cancer sites combined) cancer incidence rates in 2013 ranged from 364 to 512 cases per 100,000 persons (Table 3), and overall cancer death rates ranged from 128 to 199 deaths per 100,000 persons (Table 4). The Healthy People 2020 target (5) for overall cancer death rate (161.4 deaths per 100,000) has been reached in 21 states.

Cancer incidence (Table 5) and death (Table 6) rates increase with age. In 2013, among persons in the youngest age group (<15 years), 10,172 new cancer cases (rate: 17 cases per 100,000 persons) and 1,287 cancer deaths (rate: two deaths per 100,000 persons) were reported. Among persons aged ≥65 years, 851,505 new cancer cases (rate: 1,920 cases per 100,000 persons) and 407,558 cancer deaths (rate: 911 deaths per 100,000 persons) were reported. Overall, 55% of cancer cases and 70% of cancer deaths in 2013 occurred among persons aged ≥65 years.

In 2013, by race, blacks had the highest cancer incidence (Table 7) and death (Table 8) rates while American Indians/Alaska Natives had the lowest cancer incidence and Asians/Pacific Islanders had the lowest cancer death rates. By ethnicity, overall and for most cancer sites, Hispanics had lower cancer incidence (Table 9) and death rates (Table 10) than did non-Hispanics. Differences in cancer incidence (Figure 1) and death (Figure 2) rates by race and ethnicity might reflect differences in risk factors, screening, and treatment although rates among some populations might be under- or overestimated because of misclassification of race or ethnicity.

By state and site, cancer incidence rates in 2013 ranged from 69 to 131 per 100,000 males for prostate cancer, from 105 to 148 per 100,000 females for breast cancer, from 4 to 11 per 100,000 females for cervical cancer, from 26 to 93 per 100,000 persons for lung cancer, and from 32 to 49 per 100,000 persons for colorectal cancer (Figure 3). By state and site, cancer death rates in 2013 ranged from 12 to 33 per 100,000 males for prostate cancer, from 15 to 30 per 100,000 females for breast cancer, from 1 to 4 per 100,000 females for cervical cancer, from 19 to 70 per 100,000 persons for lung cancer, and from 11 to 20 per 100,000 persons for colorectal cancer (Figure 4).

Time Trends in Incidence and Death Rates

On the basis of data from registries meeting data quality criteria during 2004–2013, cancer incidence counts (Table 11) and rates (Table 12) are presented by state and year. Time trends in cancer incidence rates are presented by cancer site, sex, and race (Figure 5) and by cancer site, sex, and ethnicity (Figure 6). Cancer incidence rates declined from 484 cancer cases per 100,000 population in 1999 to 432 cases in 2013. Although lung cancer incidence declined steadily among men from 1999 to 2013, it increased among women from 1999 to 2005 and has since declined from 2005 to 2013. Prostate cancer incidence declined from 170 cases per 100,000 men in 1999 to 101 cases in 2013. Colorectal cancer incidence declined from 56 cases per 100,000 persons in 1999 to 38 cases in 2013. Female breast cancer incidence declined from 135 cases per 100,000 women in 1999 to 121 cases in 2005, increased to 126 cases in 2009, and declined again to 124 cases in 2013. Time trends in cancer death rates are presented by cancer site, sex, and race (Figure 7) and by cancer site, sex, and ethnicity (Figure 8). During 1999–2013, cancer death rates declined from 201 deaths per 100,000 persons in 1999 to 163 deaths in 2013; during the same period, death rates declined for each of the four most common cancers (Figure 5). Cancer death counts (Table 13) and rates (Table 14) are presented by state and year.

National cancer surveillance data help public health officials track progress toward achieving the national cancer objectives set forth in Healthy People 2020 (18). Differing rates of cancer by race, ethnicity, and state of residence indicate that for some populations, Healthy People 2020 objectives have already been achieved, whereas objectives for other populations have not been met. For the national cancer burden to be reduced and Healthy People 2020 targets to be met, behavioral and environmental factors that increase cancer risk must be reduced, and high-quality screening services, timely follow-up, and evidence-based treatments must be available and accessible to all persons. Cancer surveillance data can identify populations with high cancer rates that might benefit most from targeted cancer prevention and control efforts. Several effective evidence-based primary and secondary prevention measures, such as vaccination against infectious agents that cause cancer (i.e., hepatitis B virus and human papillomavirus), help with smoking cessation, and recommended cancer screening, when effectively implemented and sustained, could reduce the number of new cancer cases and prevent many cancer-related deaths (19). Evidence-based interventions can be implemented at both the individual level and the population level to reduce cancer risk factors, promote healthy living, and encourage cancer screening (3). The impact of these efforts can be monitored using cancer surveillance data.

Acknowledgment

Data were provided by state and regional cancer registry personnel and health department personnel.

Corresponding author: Simple Singh, Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, CDC. Telephone: 770-488-4292; E-mail: sdsingh@cdc.gov.

1Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, CDC

References

  1. US Cancer Statistics Working Group. United States cancer statistics: 1999–2013. Incidence and mortality web-based report. Atlanta, GA: US Department of Health and Human Services, CDC, National Cancer Institute; 2016. https://www.cdc.gov/uscs
  2. Heron M. Deaths: leading causes for 2013. Natl Vital Stat Rep 2016;65:1–95. https://www.cdc.gov/nchs/data/nvsr/nvsr65/nvsr65_02.pdf PubMed
  3. Colditz GA, Wolin KY, Gehlert S. Applying what we know to accelerate cancer prevention. Sci Transl Med 2012;4:127rv4. CrossRef PubMed
  4. Weir HK, Thun MJ, Hankey BF, et al. Annual report to the nation on the status of cancer, 1975. J Natl Cancer Inst 2003;95:1276–99. CrossRef PubMed
  5. US Department of Health and Human Services. Healthy people 2020. Washington, DC: US Department of Health and Human Services; 2011. https://www.healthypeople.gov/2020/topicsobjectives2020/default.aspx
  6. Fritz ARL. The SEER program code manual. Bethesda, MD: National Cancer Institute; 1998.
  7. Thornton ML, ed. Standards for cancer registries. Volume II: data standards and data dictionary, record layout version 13, 17th ed. Springfield, IL: North American Association of Central Cancer Registries; 2012.
  8. Fritz A, Percy C, Jack A. International classification of diseases of oncology. Geneva, Switzerland: World Health Organization; 2000.
  9. National Cancer Institute. Hematopoietic codes based on WHO classification of tumours of haematopoietic and lymphoid tissues. Rockville, MD: US Department of Health and Human Services, National Cancer Institute; 2008. https://seer.cancer.gov/iccc
  10. Hetzel AM. Vital Statistics System: major activities and developments, 1950–95. Atlanta, GA: US Department of Health and Human Services, CDC, National Center for Health Statistics; 1997. PHS 97-1993.
  11. World Health Organization. International statistical classification of diseases and related health problems. 10th revision. Geneva, Switzerland: World Health Organization; 1992.
  12. National Cancer Institute. US population data 1969–2014. Revised March 2016. https://seer.cancer.gov/popdata/
  13. Clegg LX, Reichman ME, Hankey BF, et al. Quality of race, Hispanic ethnicity, and immigrant status in population-based cancer registry data: implications for health disparity studies. Cancer Causes Control 2007;18:177–87. CrossRef PubMed
  14. Miniño AM, Heron MP, Murphy SL, Kochanek KD. Deaths: final data for 2004. Natl Vital Stat Rep 2007;55:1–119. PubMed
  15. Arias E, Schauman WS, Eschbach K, Sorlie PD, Backlund E. The validity of race and Hispanic origin reporting on death certificates in the United States. Vital Health Stat 2 2008;(148):1–23. https://www.cdc.gov/nchs/data/series/sr_02/sr02_148.pdf PubMed
  16. Arias E, Heron M, Hakes JK. The validity of race and Hispanic-origin reporting on death certificates in the United States: an update. Vital Health Stat 2 2016;(172):1–22. https://www.cdc.gov/nchs/data/series/sr_02/sr02_172.pdf PubMed
  17. North American Association of Central Cancer Registries Asian Pacific Islander Work Group. NAACCR Asian Pacific Islander identification algorithm. Springfield, IL: North American Association of Central Cancer Registries; 2008.
  18. Henley SJ, Singh SD, King J, Wilson RJ, Ryerson AB. Invasive cancer incidence—United States, 2010. MMWR Morb Mortal Wkly Rep 2014;63:253–9.PubMed
  19. Agency for Healthcare Research and Quality. The guide to clinical preventive services, 2014. Rockville, MD: Agency for Healthcare Research and Quality; 2015. http://www.ahrq.gov/professionals/clinicians-providers/guidelines-recommendations/guide/index.html
Return to your place in the textTABLE 1. Reported number and rate* of invasive† cancer cases, by primary cancer site and sex — United States, 2013§
Cancer site Male Female Total
No. Rate No. Rate No. Rate
All sites combined 781,451 479.0 777,679 412.6 1,559,130 439.0
Oral cavity and pharynx 29,693 17.4 12,024 6.3 41,717 11.5
Lip 1,399 0.9 547 0.3 1,946 0.6
Tongue 9,164 5.3 3,592 1.9 12,756 3.5
Salivary gland 2,629 1.7 1,779 1.0 4,408 1.3
Floor of mouth 1,368 0.8 621 0.3 1,989 0.5
Gum and other mouth 3,054 1.9 2,392 1.2 5,446 1.5
Nasopharynx 1,289 0.8 521 0.3 1,810 0.5
Tonsil 6,528 3.7 1,415 0.7 7,943 2.1
Oropharynx 1,459 0.8 447 0.2 1,906 0.5
Hypopharynx 1,893 1.1 450 0.2 2,343 0.6
Other oral cavity and pharynx 910 0.5 260 0.1 1,170 0.3
Digestive system 155,535 95.4 124,185 63.8 279,720 78.2
Esophagus 12,913 7.8 3,519 1.8 16,432 4.5
Stomach 14,429 9.0 8,719 4.5 23,148 6.6
Small intestine 4,307 2.6 3,887 2.0 8,194 2.3
Colon and rectum 71,099 44.2 65,020 33.6 136,119 38.4
Colon excluding rectum 48,175 30.3 48,748 25.0 96,923 27.4
Rectum and rectosigmoid junction 22,924 13.9 16,272 8.6 39,196 11.0
Anus, anal canal, and anorectum 2,441 1.5 4,136 2.1 6,577 1.8
Liver and intrahepatic bile duct 21,143 12.0 8,330 4.2 29,473 7.9
Gallbladder 1,280 0.8 2,654 1.3 3,934 1.1
Other biliary 3,401 2.2 2,979 1.5 6,380 1.8
Pancreas 22,787 14.1 21,590 10.9 44,377 12.4
Retroperitoneum 623 0.4 610 0.3 1,233 0.4
Peritoneum, omentum, and mesentery 170 0.1 1,804 0.9 1,974 0.6
Other digestive organs 942 0.6 937 0.5 1,879 0.5
Respiratory system 123,760 76.9 104,348 53.4 228,108 63.6
Nose, nasal cavity, and middle ear 1,435 0.9 895 0.5 2,330 0.7
Larynx 9,923 5.9 2,519 1.3 12,442 3.4
Lung and bronchus 111,907 69.8 100,677 51.5 212,584 59.4
Pleura 57 0 48 0 105 0
Trachea, mediastinum, and other respiratory organs 438 0.3 209 0.1 647 0.2
Bones and joints 1,650 1.1 1,334 0.8 2,984 0.9
Soft tissue including heart 6,093 3.9 4,965 2.8 11,058 3.3
Skin excluding basal and squamous 45,977 29.0 31,938 17.6 77,915 22.4
Melanoma of the skin 42,430 26.6 29,513 16.3 71,943 20.7
Other nonepithelial skin 3,547 2.4 2,425 1.3 5,972 1.7
Male and female breast NA NA NA NA 232,924 66.3
Female breast NA NA 230,815 123.7 NA NA
Male breast 2,109 1.3 NA NA NA NA
Female genital system NA NA 91,872 48.6 NA NA
Cervix NA NA 11,955 7.2 NA NA
Corpus and uterus, NOS NA NA 50,560 25.9 NA NA
Corpus NA NA 48,937 25.0 NA NA
Uterus, NOS NA NA 1,623 0.8 NA NA
Ovary NA NA 20,927 11.2 NA NA
Vagina NA NA 1,266 0.6 NA NA
Vulva NA NA 4,895 2.6 NA NA
Other female genital organs NA NA 2,269 1.2 NA NA
Male genital system 186,509 108.2 NA NA NA NA
Prostate 176,450 101.6 NA NA NA NA
Testis 8,351 5.5 NA NA NA NA
Penis 1,334 0.9 NA NA NA NA
Other male genital organs 374 0.2 NA NA NA NA
Urinary system 91,832 58.0 39,163 20.3 130,995 36.9
Urinary bladder 53,921 34.9 17,030 8.6 70,951 20.0
Kidney and renal pelvis 35,914 21.7 21,034 11.2 56,948 16.0
Ureter 1,185 0.8 722 0.4 1,907 0.5
Other urinary organs 812 0.5 377 0.2 1,189 0.3
Eye and orbit 1,540 1.0 1,271 0.7 2,811 0.8
Brain and other nervous system 12,092 7.6 9,756 5.5 21,848 6.5
Brain 11,453 7.2 9,036 5.1 20,489 6.0
Cranial nerves other nervous system 639 0.4 720 0.4 1,359 0.4
Endocrine system 13,052 8.1 37,033 22.2 50,085 15.3
Thyroid 11,816 7.3 35,877 21.6 47,693 14.6
Other endocrine including thymus 1,236 0.8 1,156 0.7 2,392 0.7
Lymphomas 40,056 25.3 32,899 17.6 72,955 21.1
Hodgkin lymphoma 4,574 2.9 3,659 2.3 8,233 2.6
Non-Hodgkin lymphoma 35,482 22.4 29,240 15.4 64,722 18.5
Myeloma 12,556 7.8 10,006 5.1 22,562 6.3
Leukemias 26,337 16.9 19,023 10.3 45,360 13.2
Acute lymphocytic leukemia 2,599 1.7 2,052 1.3 4,651 1.5
Chronic lymphocytic leukemia 9,223 5.8 5,869 3.0 15,092 4.2
Acute myeloid leukemia 7,921 5.1 6,419 3.5 14,340 4.2
Chronic myeloid leukemia 3,499 2.3 2,495 1.4 5,994 1.8
Other leukemias 3,095 2.0 2,188 1.1 5,283 1.5
Mesothelioma 2,441 1.6 766 0.4 3,207 0.9
Kaposi Sarcoma 985 0.7 120 0.1 1,105 0.4
Miscellaneous 29,234 19.0 26,161 13.3 55,395 15.7

Abbreviations: NA = not applicable; NOS = not otherwise specified.
*Rates are the number of cases per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups – Census P25–1130). For more information, see USCS technical notes (https://www.cdc.gov/cancer/npcr/uscs/pdf/uscs-2013-technical-notes.pdf).
†Invasive cancer excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in situ cancers except urinary bladder. Urinary bladder cancer includes invasive and in situ.
§Data are compiled from cancer registries that meet the data quality criteria for all invasive cancer sites combined (all registries except Nevada, covering approximately 99% of the U.S. population).

Return to your place in the textTABLE 2. Reported number and rate* of cancer deaths, by primary cancer site and sex — United States, 2013†
Cancer site Male Female Total
No. Rate No. Rate No. Rate
All sites combined 307,553 196.2 277,319 139.1 584,872 163.0
Oral cavity and pharynx 6,227 3.7 2,623 1.3 8,850 2.4
Lip 42 0 17 0 59 0
Tongue 1,507 0.9 701 0.4 2,208 0.6
Salivary gland 599 0.4 287 0.1 886 0.2
Floor of mouth 51 0 33 0 84 0
Gum and other mouth 706 0.4 542 0.3 1,248 0.3
Nasopharynx 467 0.3 176 0.1 643 0.2
Tonsil 657 0.4 182 0.1 839 0.2
Oropharynx 663 0.4 243 0.1 906 0.2
Hypopharynx 260 0.2 64 0 324 0.1
Other oral cavity and pharynx 1,275 0.8 378 0.2 1,653 0.4
Digestive system 85,255 52.9 63,528 31.4 148,783 41.1
Esophagus 11,731 7.1 2,958 1.5 14,689 4.0
Stomach 6,793 4.3 4,468 2.3 11,261 3.2
Small intestine 705 0.5 565 0.3 1,270 0.4
Colon and rectum 27,230 17.3 24,583 12.1 51,813 14.5
Colon excluding rectum 21,494 13.8 20,469 10.1 41,963 11.7
Rectum and rectosigmoid junction 5,736 3.5 4,114 2.1 9,850 2.7
Anus, anal canal, and anorectum 371 0.2 529 0.3 900 0.2
Liver and intrahepatic bile duct 16,300 9.5 7,732 3.8 24,032 6.5
Gallbladder 750 0.5 1,410 0.7 2,160 0.6
Other biliary 704 0.5 814 0.4 1,518 0.4
Pancreas 19,854 12.4 19,142 9.4 38,996 10.8
Retroperitoneum 111 0.1 82 0 193 0.1
Peritoneum, omentum, and mesentery 71 0 679 0.3 750 0.2
Other digestive organs 635 0.4 566 0.3 1,201 0.3
Respiratory system 89,108 56.0 71,536 35.9 160,644 44.6
Nose, nasal cavity, and middle ear 269 0.2 174 0.1 443 0.1
Larynx 2,994 1.8 735 0.4 3,729 1.0
Lung and bronchus 85,658 53.9 70,518 35.4 156,176 43.4
Pleura 42 0 24 0 66 0
Trachea, mediastinum, and other respiratory organs 145 0.1 85 0 230 0.1
Bones and joints 832 0.5 621 0.3 1,453 0.4
Soft tissue including heart 2,378 1.5 2,182 1.2 4,560 1.3
Skin excluding basal and squamous 8,723 5.6 4,025 2.0 12,748 3.6
Melanoma of the skin 6,239 4.0 3,155 1.6 9,394 2.7
Other nonepithelial skin 2,484 1.6 870 0.4 3,354 0.9
Male and female breast NA NA NA NA 41,324 11.5
Female breast NA NA 40,860 20.7 NA NA
Male breast 464 0.3 NA NA NA NA
Female genital system NA NA 29,828 15.2 NA NA
Cervix NA NA 4,217 2.3 NA NA
Corpus and uterus, NOS NA NA 9,325 4.6 NA NA
Corpus NA NA 3,903 1.9 NA NA
Uterus, NOS NA NA 5,422 2.7 NA NA
Ovary NA NA 14,276 7.2 NA NA
Vagina NA NA 437 0.2 NA NA
Vulva NA NA 1,003 0.5 NA NA
Other female genital organs NA NA 570 0.3 NA NA
Male genital system 28,390 19.7 NA NA NA NA
Prostate 27,681 19.2 NA NA NA NA
Testis 383 0.2 NA NA NA NA
Penis 270 0.2 NA NA NA NA
Other male genital organs 56 0 NA NA NA NA
Urinary system 20,765 13.6 9,747 4.8 30,512 8.5
Urinary bladder 11,294 7.7 4,463 2.1 15,757 4.4
Kidney and renal pelvis 8,967 5.6 4,939 2.5 13,906 3.9
Ureter 251 0.2 183 0.1 434 0.1
Other urinary organs 253 0.2 162 0.1 415 0.1
Eye and orbit 168 0.1 151 0.1 319 0.1
Brain and other nervous system 8,491 5.2 6,852 3.6 15,343 4.3
Endocrine system 1,322 0.8 1,457 0.8 2,779 0.8
Thyroid 838 0.5 1,012 0.5 1,850 0.5
Other endocrine including thymus 484 0.3 445 0.3 929 0.3
Lymphomas 11,801 7.8 9,402 4.7 21,203 6.0
Hodgkin lymphoma 633 0.4 457 0.2 1,090 0.3
Non-Hodgkin lymphoma 11,168 7.4 8,945 4.4 20,113 5.7
Myeloma 6,407 4.2 5,394 2.7 11,801 3.3
Leukemias 13,625 9.1 9,924 5.0 23,549 6.7
Acute lymphocytic leukemia 800 0.5 625 0.4 1,425 0.4
Chronic lymphocytic leukemia 2,786 1.9 1,871 0.9 4,657 1.3
Acute myeloid leukemia 5,590 3.7 4,121 2.1 9,711 2.8
Chronic myeloid leukemia 578 0.4 411 0.2 989 0.3
Other leukemias 3,871 2.6 2,896 1.4 6,767 1.9
Mesothelioma 1,911 1.3 586 0.3 2,497 0.7
Miscellaneous 21,647 13.8 18,583 9.1 40,230 11.2

Abbreviations: NA = not applicable; NOS = not otherwise specified.
*Rates are the number of deaths per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups – Census P25–1130). For more information, see USCS technical notes (https://www.cdc.gov/cancer/npcr/uscs/pdf/uscs-2013-technical-notes.pdf).
†Data are from the National Vital Statistics System (NVSS).

Return to your place in the textTABLE 3. Reported number and rate* of invasive† cancer cases, all sites combined, by geographic division and area — United States, 2013§
Area/State All races/ethnicities
No. Rate
Northeast 319,548 478.5
New England 82,466 464.8
Connecticut 20,510 474.2
Maine 8,366 463.8
Massachusetts 36,097 457.5
New Hampshire 7,886 479.2
Rhode Island 6,097 479.4
Vermont 3,510 437.1
Middle Atlantic 237,082 483.5
New Jersey 49,960 483.1
New York 109,560 484.3
Pennsylvania 77,562 483.0
Midwest 350,820 448.1
East North Central 242,838 448.2
Illinois 64,959 454.9
Indiana 32,372 438.8
Michigan 52,067 440.1
Ohio 62,802 452.4
Wisconsin 30,638 451.1
West North Central 107,982 447.7
Iowa 16,911 456.1
Kansas 14,572 450.9
Minnesota 27,770 451.8
Missouri 31,628 442.6
Nebraska 9,176 437.6
North Dakota 3,508 433.6
South Dakota 4,417 450.1
South 578,843 433.6
South Atlantic 316,742 432.0
Delaware 5,681 502.0
District of Columbia 2,780 445.2
Florida 108,216 413.0
Georgia 45,984 450.3
Maryland 29,824 451.0
North Carolina 49,970 445.4
South Carolina 24,809 436.9
Virginia 38,151 418.5
West Virginia 11,327 464.0
East South Central 101,032 464.8
Alabama 25,340 444.0
Kentucky 26,068 511.7
Mississippi 15,482 459.9
Tennessee 34,142 450.9
West South Central 161,069 419.0
Arkansas 15,879 454.0
Louisiana 24,184 476.3
Oklahoma 19,044 440.3
Texas 101,962 399.4
West — —
Mountain — —
Arizona 28,418 370.6
Colorado 21,764 396.1
Idaho 7,358 419.5
Montana 5,610 437.0
Nevada — —
New Mexico 8,728 363.7
Utah 9,626 393.2
Wyoming 2,517 382.0
Pacific 225,898 412.3
Alaska 2,664 410.4
California 160,911 402.8
Hawaii 7,000 419.8
Oregon 20,458 431.5
Washington 34,865 450.3

*Rates are the number of cases per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups – Census P25–1130). For more information, see USCS technical notes (https://www.cdc.gov/cancer/npcr/uscs/pdf/uscs-2013-technical-notes.pdf).
†Invasive cancer excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in situ cancers except urinary bladder.
§Data are compiled from cancer registries that meet the data quality criteria for all invasive cancer sites combined (all registries except Nevada, covering approximately 99% of the U.S. population).
Rates and counts are not presented for the West Census Region, the Mountain Census Division, or Nevada because data from Nevada are not included in this analysis.

Return to your place in the textTABLE 4. Reported cancer deaths and death rates,* all sites combined, by geographic division and area — United States, 2013†
Area/State All races/ethnicities
No. Rate
United States 584,872 163.0
Northeast 109,494 160.1
New England 28,932 159.4
Connecticut 6,619 147.8
Maine 3,227 174.8
Massachusetts 12,858 159.7
New Hampshire 2,584 158.6
Rhode Island 2,326 173.9
Vermont 1,318 164.1
Middle Atlantic 80,562 160.4
New Jersey 16,315 156.0
New York 35,735 155.5
Pennsylvania 28,512 170.0
Midwest 135,293 170.7
East North Central 94,527 173.0
Illinois 24,491 171.7
Indiana 13,258 179.4
Michigan 20,367 170.2
Ohio 24,986 177.4
Wisconsin 11,425 164.6
West North Central 40,766 165.6
Iowa 6,509 168.2
Kansas 5,379 162.9
Minnesota 9,601 155.1
Missouri 12,955 179.1
Nebraska 3,459 160.7
North Dakota 1,286 150.8
South Dakota 1,577 154.1
South 223,673 168.4
South Atlantic 120,225 162.8
Delaware 1,905 167.1
District of Columbia 1,095 177.7
Florida 42,734 154.9
Georgia 16,417 168.1
Maryland 10,608 163.0
North Carolina 18,589 167.7
South Carolina 9,745 174.0
Virginia 14,414 162.3
West Virginia 4,718 190.5
East South Central 40,890 189.5
Alabama 10,328 182.1
Kentucky 10,082 199.3
Mississippi 6,527 196.5
Tennessee 13,953 185.4
West South Central 62,558 167.3
Arkansas 6,688 189.6
Louisiana 9,419 188.7
Oklahoma 8,039 185.4
Texas 38,412 156.9
West 116,412 148.3
Mountain 35,623 146.1
Arizona 11,347 146.4
Colorado 7,357 139.2
Idaho 2,707 156.3
Montana 1,997 154.0
Nevada 4,817 164.9
New Mexico 3,481 145.1
Utah 2,971 127.9
Wyoming 946 147.7
Pacific 80,789 149.3
Alaska 1,016 173.1
California 57,714 146.6
Hawaii 2,332 134.9
Oregon 7,799 163.2
Washington 11,928 156.3

*Rates are the number of deaths per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups – Census P25–1130). For more information, see USCS technical notes (https://www.cdc.gov/cancer/npcr/uscs/pdf/uscs-2013-technical-notes.pdf).
†Data are from the National Vital Statistics System (NVSS).

Return to your place in the textTABLE 5. Reported number and rate* of invasive† cancer cases, by primary cancer site and age group — United States, 2013§
Cancer site Age group (yrs) Total (all ages)
<15 15–24 25–39 40–64 ≥65
No. Rate No. Rate No. Rate No. Rate No. Rate No. Rate (crude)
All sites combined 10,172 16.8 12,482 28.6 59,280 95.7 625,691 606.5 851,505 1,920.3 1,559,130 497.0
Oral cavity and pharynx 107 0.2 226 0.5 1,138 1.8 21,699 21.0 18,547 41.8 41,717 13.3
Esophagus — — — — 131 0.2 6,513 6.3 9,782 22.1 16,432 5.2
Stomach — — 67 0.2 639 1.0 8,301 8.0 14,137 31.9 — 7.4
Colon and rectum 48 0.1 359 0.8 3,463 5.6 52,994 51.4 79,255 178.7 136,119 43.4
Liver and intrahepatic bile duct 180 0.3 76 0.2 307 0.5 15,104 14.6 13,806 31.1 29,473 9.4
Pancreas — — 57 0.1 446 0.7 14,506 14.1 29,361 66.2 — 14.1
Larynx — — — — 93 0.2 5,998 5.8 6,337 14.3 12,442 4.0
Lung and bronchus 35 0.1 101 0.2 948 1.5 65,462 63.5 146,038 329.3 212,584 67.8
Melanomas of the skin 120 0.2 912 2.1 5,477 8.8 29,698 28.8 35,736 80.6 71,943 22.9
Female breast — — 189 0.9 9,965 32.3 117,033 222.1 103,622 415.9 — 144.8
Cervix — — 120 0.6 2,796 9.1 6,605 12.5 2,428 9.7 — 7.5
Corpus and uterus, NOS — — 62 0.3 1,607 5.2 26,844 51.0 22,044 88.5 — 31.7
Ovary 115 0.4 346 1.6 1,028 3.3 9,498 18.0 9,940 39.9 20,927 13.1
Prostate — — — — 94 0.3 74,866 148.3 101,478 522.4 176,450 114.3
Testis 69 0.2 1,464 6.5 4,222 13.6 2,396 4.7 200 1.0 8,351 5.4
Urinary bladder 20 0 55 0.1 513 0.8 17,787 17.2 52,576 118.6 70,951 22.6
Kidney and renal pelvis 549 0.9 161 0.4 2,140 3.5 25,809 25.0 28,289 63.8 56,948 18.2
Brain and nervous system 2,170 3.6 954 2.2 2,023 3.3 8,381 8.1 8,320 18.8 21,848 7.0
Thyroid 222 0.4 1,936 4.4 9,820 15.8 25,477 24.7 10,238 23.1 47,693 15.2
Hodgkin lymphoma 327 0.5 1,516 3.5 2,183 3.5 2,631 2.6 1,576 3.6 8,233 2.6
Non-Hodgkin lymphoma 591 1.0 923 2.1 2,909 4.7 23,046 22.3 37,253 84.0 64,722 20.6
Myeloma — — — — 278 0.4 7,953 7.7 14,313 32.3 22,562 7.2
Leukemias 2,896 4.8 1,241 2.8 2,162 3.5 13,922 13.5 25,139 56.7 45,360 14.5
Mesothelioma — — — — 46 0.1 676 0.7 2,478 5.6 3,207 1.0
Kaposi Sarcoma — — 43 0.1 300 0.5 460 0.4 301 0.7 — 0.4

Abbreviation: NOS = not otherwise specified.
*Rates are the number of cases per 100,000 persons. For more information, see USCS technical notes (https://www.cdc.gov/cancer/npcr/uscs/pdf/uscs-2013-technical-notes.pdf).
†Invasive cancer excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in situ cancers except urinary bladder. Urinary bladder cancer includes invasive and in situ.
§Data are compiled from cancer registries that meet the data quality criteria for all invasive cancer sites combined (all registries except Nevada, covering approximately 99% of the U.S. population).
Counts and rates are suppressed if <16 cases were reported in a specific category. Some counts and rates are suppressed as complementary cell suppression.

Return to your place in the textTABLE 6. Reported number and rate* of cancer deaths, by primary cancer site and age group — United States, 2013†
Cancer site Age group (yrs) Total (all ages)
<15 15–24 25–39 40–64 ≥65
No. Rate No. Rate No. Rate No. Rate No. Rate No. Rate (crude)
All sites combined 1,287 2.1 1,496 3.4 7,446 11.9 167,085 160.5 407,558 911.3 584,872 184.8
Oral cavity and pharynx —§ — — — 114 0.2 3,608 3.5 5,111 11.4 8,850 2.8
Esophagus — — — — 87 0.1 5,161 5.0 9,441 21.1 14,689 4.6
Stomach — — 19 0 287 0.5 3,504 3.4 7,450 16.7 — 3.6
Colon and rectum — — 46 0.1 805 1.3 15,356 14.8 35,603 79.6 — 16.4
Liver and intrahepatic bile duct 33 0.1 32 0.1 211 0.3 10,089 9.7 13,667 30.6 24,032 7.6
Pancreas — — — — 183 0.3 10,756 10.3 28,045 62.7 38,996 12.3
Larynx — — — — — — 1,350 1.3 2,372 5.3 3,729 1.2
Lung and bronchus — — 22 0 383 0.6 42,733 41.1 113,032 252.7 — 49.3
Melanomas of the skin — — 26 0.1 352 0.6 3,082 3.0 5,932 13.3 — 3.0
Female breast — — — — 961 3.1 15,774 29.7 24,114 96.0 40,860 25.4
Cervix — — — — 422 1.4 2,369 4.5 1,413 5.6 4,217 2.6
Corpus and uterus, NOS — — — — 106 0.3 3,024 5.7 6,194 24.7 9,325 5.8
Ovary — — 32 0.1 170 0.5 4,614 8.7 9,458 37.7 — 8.9
Prostate — — — — — — 3,033 6.0 24,638 125.7 27,681 17.8
Testis — — 32 0.1 130 0.4 167 0.3 53 0.3 — 0.2
Urinary bladder — — — — 31 0 2,450 2.4 13,275 29.7 15,757 5.0
Kidney and renal pelvis 40 0.1 19 0 138 0.2 4,256 4.1 9,453 21.1 13,906 4.4
Brain and nervous system 437 0.7 241 0.5 751 1.2 6,080 5.8 7,834 17.5 15,343 4.8
Thyroid — — — — 17 0 473 0.5 1,357 3.0 1,850 0.6
Hodgkin lymphoma — — 32 0.1 137 0.2 334 0.3 583 1.3 — 0.3
Non-Hodgkin lymphoma 29 0 91 0.2 344 0.5 4,089 3.9 15,560 34.8 20,113 6.4
Myeloma — — — — 33 0.1 2,478 2.4 9,289 20.8 11,801 3.7
Leukemias 350 0.6 345 0.8 643 1.0 4,574 4.4 17,637 39.4 23,549 7.4
Mesothelioma — — — — — — 443 0.4 2,045 4.6 2,497 0.8

Abbreviation: NOS = not otherwise specified.
*Rates are the number of deaths per 100,000 persons. For more information, see USCS technical notes (https://www.cdc.gov/cancer/npcr/uscs/pdf/uscs-2013-technical-notes.pdf).
†Data are from the National Vital Statistics System (NVSS).
§Counts and rates are suppressed if <16 cases were reported in a specific category. Some counts and rates are suppressed as complementary cell suppression.

Return to your place in the textTABLE 7. Reported number and rate* of invasive† cancer cases, by primary cancer site and race§ — United States, 2013
Cancer site AI/AN A/PI Black White
No. Rate No. Rate No. Rate No. Rate
All sites combined 8,676 276.4 47,802 284.0 170,123 443.6 1,304,263 439.3
Oral cavity and pharynx 244 7.1 1,373 7.8 3,644 9.0 35,858 11.8
Lip —** — 18 0.1 26 0.1 1,816 0.6
Tongue 69 1.9 302 1.8 813 2.0 11,402 3.7
Salivary gland 17 0.5 186 1.1 423 1.1 3,710 1.3
Floor of mouth — — 36 0.2 221 0.5 1,693 0.5
Gum and other mouth 24 0.8 216 1.3 502 1.3 4,590 1.5
Nasopharynx 16 0.5 411 2.2 268 0.7 1,090 0.4
Tonsil 46 1.2 114 0.6 632 1.5 7,073 2.3
Oropharynx 17 0.5 19 0.1 267 0.6 1,590 0.5
Hypopharynx 19 0.5 60 0.4 362 0.9 1,889 0.6
Other oral cavity and pharynx — — — — 130 0.3 1,005 0.3
Digestive system 1,919 63.3 11,416 70.1 35,835 94.9 227,267 75.5
Esophagus 93 3.2 326 2.0 1,604 4.2 14,289 4.7
Stomach 202 6.9 1,694 10.7 3,563 9.9 17,338 5.8
Small intestine 33 1.0 184 1.1 1,406 3.7 6,482 2.2
Colon and rectum 905 29.9 4,921 29.6 16,843 44.9 111,623 37.5
Colon excluding rectum 597 20.6 3,138 19.3 12,379 33.5 79,695 26.8
Rectum and rectosigmoid junction 308 9.3 1,783 10.3 4,464 11.4 31,928 10.8
Anus, anal canal, and anorectum 33 0.9 84 0.5 729 1.8 5,661 1.9
Liver and intrahepatic bile duct 312 9.3 2,037 12.3 4,422 10.4 22,350 7.1
Gallbladder 43 1.7 196 1.2 626 1.8 3,019 1.0
Other biliary 36 1.3 343 2.2 604 1.7 5,331 1.8
Pancreas 221 7.7 1,433 9.2 5,492 15.1 36,908 12.1
Retroperitoneum — — 59 0.3 146 0.4 1,011 0.4
Peritoneum, omentum, and mesentery 17 0.5 62 0.4 164 0.4 1,720 0.6
Other digestive organs 18 0.6 77 0.5 236 0.7 1,535 0.5
Respiratory system 1,251 43.8 5,756 36.8 24,488 66.2 195,297 64.4
Nose, nasal cavity, and middle ear — — 94 0.6 252 0.6 1,930 0.7
Larynx 58 1.8 177 1.1 1,672 4.2 10,402 3.4
Lung and bronchus 1,175 41.5 5,446 35.0 22,489 61.2 182,352 60.1
Pleura — — — — — — 92 0
Trachea, mediastinum, and other respiratory organs — — 37 0.2 68 0.2 521 0.2
Bones and joints 27 0.7 99 0.5 333 0.8 2,466 1.0
Soft tissue including heart 80 2.4 414 2.4 1,283 3.3 9,058 3.2
Skin excluding basal and squamous 192 6.1 323 1.9 746 2.0 72,417 25.1
Melanomas of the skin 161 5.0 213 1.3 362 1.0 67,291 23.3
Other nonepithelial skin 31 1.1 110 0.7 384 1.0 5,126 1.8
Male and female breast 1,279 38.6 8,946 49.9 27,160 70.1 192,817 66.0
Female breast 1,272 72.3 8,914 91.1 26,854 122.9 191,077 124.4
Male breast — — 32 0.4 306 1.9 1,740 1.3
Female genital system 624 34.2 3,529 35.8 10,267 46.7 76,112 49.1
Cervix 118 6.3 588 5.9 1,936 9.0 9,058 7.0
Corpus and uterus, NOS 319 17.3 1,848 18.5 5,546 24.8 42,116 26.2
Corpus 309 16.7 1,796 18.0 5,185 23.2 40,946 25.4
Uterus, NOS — — 52 0.5 361 1.6 1,170 0.7
Ovary 145 8.1 887 9.2 1,969 9.1 17,688 11.4
Vagina — — 40 0.4 189 0.9 1,017 0.6
Vulva 25 1.6 73 0.8 395 1.8 4,324 2.7
Other female genital organs — — 93 0.9 232 1.1 1,909 1.2
Male genital system 855 58.3 4,079 55.0 28,677 166.9 145,637 100.1
Prostate 762 54.0 3,853 52.5 28,208 164.4 136,604 92.5
Testis 80 3.3 178 1.8 285 1.4 7,598 6.4
Penis — — 26 0.4 144 0.9 1,133 0.9
Other male genital organs — — 22 0.3 40 0.2 302 0.2
Urinary system 746 24.3 2,618 16.4 11,088 29.7 114,606 38.3
Urinary bladder 232 8.7 1,247 8.3 4,040 11.6 64,236 21.3
Kidney and renal pelvis 500 15.0 1,274 7.5 6,864 17.6 47,630 16.1
Ureter — — 65 0.4 71 0.2 1,749 0.6
Other urinary organs — — 32 0.2 113 0.3 991 0.3
Eye and orbit — — 56 0.3 112 0.3 2,537 0.9
Brain and other nervous system 112 3.0 622 3.6 1,639 4.0 19,211 7.0
Brain 104 2.8 566 3.3 1,487 3.7 18,096 6.5
Cranial nerves other nervous system — — 56 0.3 152 0.4 1,115 0.4
Endocrine system 315 8.3 2,944 15.7 4,140 10.2 41,563 15.8
Thyroid 298 7.8 2,796 14.9 3,759 9.3 39,758 15.1
Other endocrine including thymus 17 0.5 148 0.9 381 0.9 1,805 0.7
Lymphomas 345 10.9 2,262 13.6 6,408 16.4 62,525 21.6
Hodgkin lymphoma 37 1.0 216 1.1 1,109 2.6 6,688 2.6
Non-Hodgkin lymphoma 308 9.9 2,046 12.4 5,299 13.8 55,837 19.0
Myeloma 124 4.3 595 3.7 4,659 12.8 16,845 5.6
Leukemias 234 7.3 1,206 7.1 3,811 10.1 39,006 13.6
Acute lymphocytic leukemia 41 0.9 205 1.1 385 0.9 3,896 1.6
Chronic lymphocytic leukemia 49 1.8 144 0.9 1,115 3.1 13,229 4.3
Acute myeloid leukemia 80 2.6 539 3.2 1,268 3.4 12,307 4.3
Chronic myeloid leukemia 31 0.9 183 1.0 599 1.5 5,013 1.8
Other leukemias 33 1.2 135 0.8 444 1.2 4,561 1.6
Mesothelioma — — 46 0.3 146 0.4 2,982 1.0
Kaposi Sarcoma — — 29 0.2 292 0.7 695 0.3
Miscellaneous 298 10.7 1,489 9.8 5,395 15.2 47,364 15.8

Abbreviations: AI/AN = American Indian/Alaska Native; A/PI = Asian/Pacific Islander; NOS = not otherwise specified.
*Rates are the number of cases per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups – Census P25–1130). For more information, see USCS technical notes (https://www.cdc.gov/cancer/npcr/uscs/pdf/uscs-2013-technical-notes.pdf).
†Invasive cancer excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in situ cancers except urinary bladder. Urinary bladder cancer includes invasive and in situ.
§Rates are not presented for persons of unknown or other race; therefore, categories do not sum to total. Data for specified racial populations other than white and black should be interpreted with caution. For more information, see USCS technical notes (https://www.cdc.gov/cancer/npcr/uscs/pdf/uscs-2013-technical-notes.pdf#nameddest=IntRaceEthnicityData).
**Counts and rates are suppressed if <16 cases were reported.

Return to your place in the textTABLE 8. Reported number and rate* of cancer deaths, by primary site and race†— United States, 2013§
Cancer site AI/AN A/I Black White
No. Rate No. Rate No. Rate No. Rate
All sites combined 3,109 111.2 15,703 100.0 67,952 189.5 498,108 163.3
Oral cavity and pharynx 32 1.0 314 1.9 1,076 2.8 7,428 2.4
Lip — — — — — — 55 0
Tongue — — 53 0.3 203 0.5 1,945 0.6
Salivary gland — — 22 0.1 75 0.2 788 0.3
Floor of mouth — — — — — — 74 0
Gum and other mouth — — 46 0.3 122 0.3 1,077 0.3
Nasopharynx — — 127 0.7 95 0.2 416 0.1
Tonsil — — — — 86 0.2 736 0.2
Oropharynx — — 18 0.1 139 0.4 746 0.2
Hypopharynx — — — — 70 0.2 246 0.1
Other oral cavity and pharynx — — 28 0.2 275 0.7 1,345 0.4
Digestive system 1,020 35.3 5,608 35.5 19,240 53.0 122,915 40.0
Esophagus 74 2.6 271 1.7 1,308 3.5 13,036 4.2
Stomach 96 3.5 808 5.1 1,964 5.6 8,393 2.8
Small intestine — — 29 0.2 219 0.6 1,017 0.3
Colon and rectum 351 12.6 1,557 9.7 6,854 19.3 43,051 14.1
Colon excluding rectum 271 10.0 1,215 7.7 5,772 16.3 34,705 11.4
Rectum and rectosigmoid junction 80 2.6 342 2.1 1,082 3.0 8,346 2.7
Anus, anal canal, and anorectum — — 22 0.1 104 0.3 769 0.3
Liver and intrahepatic bile duct 256 8.0 1,542 9.5 3,385 8.4 18,849 6.0
Gallbladder 19 0.8 120 0.8 329 0.9 1,692 0.6
Other biliary — — 58 0.4 137 0.4 1,313 0.4
Pancreas 188 6.8 1,124 7.5 4,737 13.4 32,947 10.7
Retroperitoneum — — — — 20 0.1 161 0.1
Peritoneum, omentum, and mesentery — — 19 0.1 48 0.1 679 0.2
Other digestive organs — — 46 0.3 135 0.4 1,008 0.3
Respiratory system 777 28.8 3,622 23.8 17,584 48.8 138,661 45.3
Nose, nasal cavity, and middle ear — — 20 0.1 41 0.1 380 0.1
Larynx 19 0.6 53 0.3 599 1.6 3,058 1.0
Lung and bronchus 754 28.0 3,539 23.3 16,906 46.9 134,977 44.1
Pleura — — — — — — 60 0
Trachea, mediastinum, and other respiratory organs — — — — 35 0.1 186 0.1
Bones and joints — — 41 0.2 164 0.4 1,238 0.4
Soft tissue including heart 30 0.9 156 0.9 552 1.4 3,822 1.3
Skin excluding basal and squamous 30 1.0 81 0.5 306 0.8 12,331 4.1
Melanomas of the skin 16 0.5 46 0.3 141 0.4 9,191 3.1
Other nonepithelial skin — — 35 0.2 165 0.4 3,140 1.0
Male and female breast 166 5.5 1,059 6.2 6,167 16.6 33,932 11.2
Female breast 166 10.1 1,048 11.0 6,086 28.2 33,560 20.3
Male breast — — — — 60 0.4 340 0.3
Female genital system 148 9.0 899 9.6 4,035 19.0 24,746 15.0
Cervix 30 1.7 187 1.9 838 3.9 3,162 2.2
Corpus and uterus, NOS 37 2.2 263 2.8 1,764 8.3 7,261 4.3
Corpus 16 1.0 97 1.0 682 3.2 3,108 1.8
Uterus, NOS 21 1.3 166 1.8 1,082 5.1 4,153 2.5
Ovary 73 4.5 416 4.5 1,254 6.0 12,533 7.5
Vagina — — — — 54 0.3 373 0.2
Vulva — — — — 64 0.3 924 0.5
Other female genital organs — — — — 61 0.3 493 0.3
Male genital system 138 14.5 492 8.9 4,594 39.5 23,166 18.4
Prostate 131 14.2 473 8.6 4,528 39.1 22,549 18.0
Testis — — — — — — 354 0.3
Penis — — — — 42 0.3 218 0.2
Other male genital organs — — — — — — 45 0
Urinary system 167 6.1 550 3.7 2,480 7.2 27,315 8.9
Urinary bladder 48 1.7 248 1.8 1,167 3.5 14,294 4.7
Kidney and renal pelvis 118 4.3 272 1.7 1,260 3.5 12,256 4.0
Ureter — — 21 0.1 18 0.1 394 0.1
Other urinary organs — — — — 35 0.1 371 0.1
Eye and orbit — — — — — — 310 0.1
Brain and other nervous system 68 2.1 376 2.2 941 2.4 13,958 4.7
Endocrine system 20 0.7 141 0.9 308 0.9 2,310 0.8
Thyroid 17 0.6 98 0.7 182 0.5 1,553 0.5
Other endocrine including thymus — — 43 0.2 126 0.3 757 0.3
Lymphomas 91 3.5 608 4.0 1,568 4.4 18,936 6.3
Hodgkin lymphoma — — 21 0.1 108 0.3 958 0.3
Non-Hodgkin lymphoma 88 3.4 587 3.9 1,460 4.1 17,978 5.9
Myeloma 63 2.3 214 1.4 2,157 6.4 9,367 3.1
Leukemias 104 3.7 580 3.7 1,987 5.7 20,878 7.0
Acute lymphocytic leukemia — — 53 0.3 136 0.3 1,221 0.5
Chronic lymphocytic leukemia — — 33 0.2 378 1.1 4,236 1.4
Acute myeloid leukemia 48 1.7 317 2.0 778 2.2 8,568 2.9
Chronic myeloid leukemia — — 22 0.1 99 0.3 861 0.3
Other leukemias 24 1.0 155 1.0 596 1.7 5,992 2.0
Mesothelioma — — 35 0.2 112 0.3 2,342 0.8
Miscellaneous 237 8.7 925 6.0 4,667 13.0 34,401 11.2

Abbreviations: AI/AN = American Indian/Alaska Native; A/PI = Asian/Pacific Islander; NOS = not otherwise specified.
*Rates are the number of deaths per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups – Census P25–1130). For more information, see USCS technical notes (https://www.cdc.gov/cancer/npcr/uscs/pdf/uscs-2013-technical-notes.pdf).
†Data for specified racial populations other than white and black should be interpreted with caution. For more information, see USCS technical notes (https://www.cdc.gov/cancer/npcr/uscs/pdf/uscs-2013-technical-notes.pdf#nameddest=IntRaceEthnicityData).
§Data are from the National Vital Statistics System (NVSS).
Counts and rates are suppressed if <16 cases were reported.

Return to your place in the textTABLE 9. Reported number and rate* of invasive† cancer cases, by primary cancer site and ethnicity§ — United States, 2013
Cancer site Hispanic Non-Hispanic
No. Rate No. Rate
All sites combined 117,332 343.7 1,403,357 450.8
Oral cavity and pharynx 2,360 6.8 38,279 12.1
Lip 89 0.3 1,811 0.6
Tongue 653 1.9 11,797 3.7
Salivary gland 298 0.8 3,986 1.3
Floor of mouth 99 0.3 1,836 0.6
Gum and other mouth 346 1.1 4,942 1.6
Nasopharynx 152 0.4 1,607 0.5
Tonsil 438 1.2 7,317 2.3
Oropharynx 98 0.3 1,753 0.5
Hypopharynx 134 0.4 2,133 0.7
Other oral cavity and pharynx 53 0.2 1,097 0.3
Digestive system 25,401 79.0 247,673 78.5
Esophagus 800 2.6 15,228 4.7
Stomach 3,129 9.8 19,455 6.2
Small intestine 590 1.8 7,379 2.4
Colon and rectum 10,997 33.8 121,907 39.1
Colon excluding rectum 7,562 23.9 87,066 27.9
Rectum and rectosigmoid junction 3,435 10.0 34,841 11.2
Anus, anal canal, and anorectum 440 1.3 5,977 1.9
Liver and intrahepatic bile duct 4,311 12.9 24,545 7.4
Gallbladder 586 1.9 3,244 1.0
Other biliary 735 2.5 5,524 1.7
Pancreas 3,357 11.1 39,910 12.5
Retroperitoneum 141 0.4 1,055 0.4
Peritoneum, omentum, and mesentery 130 0.4 1,798 0.6
Other digestive organs 185 0.6 1,651 0.5
Respiratory system 10,261 34.9 212,149 66.6
Nose, nasal cavity, and middle ear 234 0.7 2,036 0.7
Larynx 809 2.5 11,310 3.5
Lung and bronchus 9,125 31.5 198,162 62.2
Pleura —** — 88 0
Trachea, mediastinum, and other respiratory organs 80 0.2 553 0.2
Bones and joints 424 0.9 2,487 0.9
Soft tissue including heart 1,210 3.0 9,571 3.3
Skin excluding basal and squamous 1,842 5.3 74,086 24.6
Melanomas of the skin 1,535 4.4 68,543 22.8
Other nonepithelial skin 307 0.9 5,543 1.8
Male and female breast 18,155 50.1 208,425 68.3
Female breast 18,041 93.4 206,497 127.4
Male breast 114 0.8 1,928 1.3
Female genital system 9,034 45.4 80,637 49.0
Cervix 2,010 9.3 9,689 7.0
Corpus and uterus, NOS 4,517 23.1 44,800 26.1
Corpus 4,301 21.9 43,444 25.3
Uterus, NOS 216 1.2 1,356 0.8
Ovary 1,912 9.7 18,507 11.3
Vagina 129 0.7 1,100 0.6
Vulva 295 1.7 4,492 2.7
Other female genital organs 171 0.9 2,049 1.2
Male genital system 14,008 93.6 167,698 110.0
Prostate 12,403 87.5 159,452 103.2
Testis 1,400 4.7 6,782 5.7
Penis 184 1.2 1,116 0.8
Other male genital organs 21 0.1 348 0.3
Urinary system 8,926 27.7 119,098 38.0
Urinary bladder 3,135 11.0 66,222 20.9
Kidney and renal pelvis 5,634 16.1 50,006 16.1
Ureter 96 0.4 1,760 0.6
Other urinary organs 61 0.2 1,110 0.4
Eye and orbit 216 0.5 2,548 0.9
Brain and other nervous system 2,147 5.2 19,193 6.7
Brain 1,966 4.8 18,049 6.3
Cranial nerves other nervous system 181 0.4 1,144 0.4
Endocrine system 5,965 13.8 42,877 15.7
Thyroid 5,700 13.2 40,801 14.9
Other endocrine including thymus 265 0.6 2,076 0.8
Lymphomas 6,775 19.2 64,396 21.4
Hodgkin lymphoma 1,084 2.4 6,934 2.7
Non-Hodgkin lymphoma 5,691 16.9 57,462 18.7
Myeloma 1,908 6.1 20,128 6.4
Leukemias 4,243 10.7 40,185 13.4
Acute lymphocytic leukemia 1,217 2.1 3,361 1.4
Chronic lymphocytic leukemia 621 2.1 14,188 4.4
Acute myeloid leukemia 1,321 3.6 12,690 4.2
Chronic myeloid leukemia 597 1.5 5,260 1.8
Other leukemias 487 1.4 4,686 1.6
Mesothelioma 222 0.7 2,895 0.9
Kaposi Sarcoma 244 0.6 844 0.3
Miscellaneous 3,991 13.2 50,188 16.0

Abbreviation: NOS = not otherwise specified.
*Rates are the number of cases per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups – Census P25–1130). For more information, see USCS technical notes (https://www.cdc.gov/cancer/npcr/uscs/pdf/uscs-2013-technical-notes.pdf).
†Invasive cancer excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in situ cancers except urinary bladder. Urinary bladder cancer includes invasive and in situ.
§Rates and counts are not presented for persons of unknown ethnicity; therefore, categories do not sum to total. Data for specified ethnic populations should be interpreted with caution. For more information, see USCS technical notes (https://www.cdc.gov/cancer/npcr/uscs/pdf/uscs-2013-technical-notes.pdf#nameddest=IntRaceEthnicityData).
Data are compiled from cancer registries that meet the data quality criteria for all invasive cancer sites combined and have information on ethnicity (all registries except Nevada and Virginia, covering approximately 97% of the U.S. population). Data from Nevada did not meet the data quality criteria and information about ethnicity was missing on 85% of the cases from Virginia.
**Counts and rates are suppressed if <16 cases were reported. Some counts and rates are suppressed as complementary cell suppression.

Return to your place in the textTABLE 10. Reported number and rate* of cancer deaths, by primary cancer site and ethnicity† — United States, 2013§
Cancer site Hispanic Non-Hispanic
No. Rate No. Rate
All sites combined 35,147 114.7 548,516 167.2
Oral cavity and pharynx 455 1.4 8,364 2.5
Lip — — 58 0
Tongue 114 0.3 2,086 0.6
Salivary gland 39 0.1 845 0.3
Floor of mouth — — 81 0
Gum and other mouth 65 0.2 1,178 0.4
Nasopharynx 37 0.1 605 0.2
Tonsil 38 0.1 798 0.2
Oropharynx 58 0.2 843 0.3
Hypopharynx 23 0.1 298 0.1
Other oral cavity and pharynx 77 0.2 1,572 0.5
Digestive system 11,914 38.7 136,551 41.3
Esophagus 593 1.9 14,060 4.2
Stomach 1,633 5.1 9,605 3.0
Small intestine 78 0.3 1,190 0.4
Colon and rectum 3,568 11.7 48,133 14.7
Colon excluding rectum 2,902 9.6 38,973 11.9
Rectum and rectosigmoid junction 666 2.0 9,160 2.8
Anus, anal canal, and anorectum 50 0.1 846 0.3
Liver and intrahepatic bile duct 2,994 9.3 20,974 6.2
Gallbladder 254 0.9 1,905 0.6
Other biliary 123 0.4 1,393 0.4
Pancreas 2,473 8.4 36,458 11.0
Retroperitoneum 19 0.1 174 0.1
Peritoneum, omentum, and mesentery 40 0.1 706 0.2
Other digestive organs 89 0.3 1,107 0.3
Respiratory system 5,629 19.7 154,680 46.8
Nose, nasal cavity, and middle ear 33 0.1 408 0.1
Larynx 219 0.7 3,498 1.0
Lung and bronchus 5,353 18.8 150,502 45.6
Pleura — — 62 0
Trachea, mediastinum, and other respiratory organs 20 0.1 210 0.1
Bones and joints 188 0.5 1,261 0.4
Soft tissue including heart 392 1.0 4,161 1.3
Skin excluding basal and squamous 357 1.2 12,372 3.8
Melanomas of the skin 236 0.7 9,151 2.9
Other nonepithelial skin 121 0.4 3,221 1.0
Male and female breast 2,695 8.0 38,540 11.8
Female breast 2,671 14.5 38,104 21.3
Male breast 24 0.2 436 0.3
Female genital system 2,280 12.6 27,492 15.4
Cervix 521 2.5 3,682 2.3
Corpus and uterus, NOS 679 3.8 8,629 4.7
Corpus 222 1.2 3,673 2.0
Uterus, NOS 457 2.6 4,956 2.7
Ovary 942 5.3 13,312 7.4
Vagina 39 0.2 398 0.2
Vulva 63 0.4 939 0.5
Other female genital organs 36 0.2 532 0.3
Male genital system 1,758 16.3 26,567 19.9
Prostate 1,634 15.8 25,983 19.4
Testis 80 0.3 302 0.2
Penis 41 0.2 229 0.2
Other male genital organs — — 53 0
Urinary system 1,720 5.9 28,730 8.7
Urinary bladder 630 2.4 15,098 4.6
Kidney and renal pelvis 1,053 3.4 12,820 3.9
Ureter 18 0.1 416 0.1
Other urinary organs 19 0.1 396 0.1
Eye and orbit 17 0.1 302 0.1
Brain and other nervous system 1,046 2.9 14,279 4.5
Endocrine system 275 0.8 2,498 0.8
Thyroid 177 0.6 1,670 0.5
Other endocrine including thymus 98 0.2 828 0.3
Lymphomas 1,593 5.3 19,571 6.1
Hodgkin lymphoma 134 0.4 954 0.3
Non-Hodgkin lymphoma 1,459 4.9 18,617 5.7
Myeloma 774 2.7 11,003 3.4
Leukemias 1,677 5.1 21,833 6.8
Acute lymphocytic leukemia 320 0.7 1,103 0.4
Chronic lymphocytic leukemia 146 0.6 4,502 1.4
Acute myeloid leukemia 666 2.0 9,032 2.8
Chronic myeloid leukemia 70 0.2 916 0.3
Other leukemias 475 1.6 6,280 2.0
Mesothelioma 125 0.4 2,369 0.7
Miscellaneous 2,238 7.5 37,898 11.5

Abbreviation: NOS = not otherwise specified.
*Rates are the number of deaths per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups – Census P25–1130). For more information, see USCS technical notes (https://www.cdc.gov/cancer/npcr/uscs/pdf/uscs-2013-technical-notes.pdf).
†Data are from the National Vital Statistics System (NVSS).
§Rates are not presented for persons of unknown ethnicity; therefore, categories do not sum to total. Data for specified ethnic populations should be interpreted with caution. For more information, see USCS technical notes (https://www.cdc.gov/cancer/npcr/uscs/pdf/uscs-2013-technical-notes.pdf#nameddest=IntRaceEthnicityData).
Counts and rates are suppressed if <16 cases were reported.

Return to your place in the textFIGURE 1. Age-adjusted rate* of invasive† cancer cases for most common sites, by sex and race/ethnicity§ — United States, 2013

Abbreviations: AI/AN = American Indian/Alaska Native; A/PI = Asian/Pacific Islander.

Sources: CDC’s National Program of Cancer Registries and National Cancer Institute’s Surveillance, Epidemiology, and End Results program.

* Rates are the number of cases per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups – Census P25–1130). For more information, see USCS technical notes (https://www.cdc.gov/cancer/npcr/uscs/pdf/uscs-2013-technical-notes.pdf).

† Invasive cancer excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in situ cancers except urinary bladder.

§ Race categories are not mutually exclusive from Hispanic origin. The Hispanic category excludes any cases from Virginia because information about ethnicity was missing on 85% of cases. Rates are not presented for persons of unknown or other race. Data for specified racial or ethnic populations other than white and black should be interpreted with caution. For more information, see USCS technical notes (https://www.cdc.gov/cancer/npcr/uscs/pdf/uscs-2013-technical-notes.pdf#nameddest=IntRaceEthnicityData).

Data are compiled from cancer registries that meet the data quality criteria for all invasive cancer sites combined (all registries except Nevada, covering approximately 99% of the U.S. population). Caution should be used when comparing incidence and death rates because of the difference in population coverage.

Return to your place in the textFIGURE 2. Age-adjusted rate* of cancer deaths for most common sites, by sex and race/ethnicity† — United States, 2013§

Abbreviations: AI/AN = American Indian/Alaska Native; A/PI = Asian/Pacific Islander.

* Rates are the number of cases per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups – Census P25–1130). For more information, see USCS technical notes (https://www.cdc.gov/cancer/npcr/uscs/pdf/uscs-2013-technical-notes.pdf).

† Data are from the National Vital Statistics System (NVSS). Data for death rates cover 100% of the U.S. population. Use caution when comparing incidence and death rates because of potential differences in population coverage.

§ Race categories are not mutually exclusive from Hispanic origin. Rates are not presented for persons of unknown or other race. Data for specified racial or ethnic populations other than white and black should be interpreted with caution. For more information, see USCS technical notes (https://www.cdc.gov/cancer/npcr/uscs/pdf/uscs-2013-technical-notes.pdf#nameddest=IntRaceEthnicityData).

Return to your place in the textFIGURE 3. Age-adjusted rate* of invasive† cancer cases, by primary cancer site and state — United States, 2013§

* Rates are the number of cases per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups – Census P25–1130). Rates are presented by quartiles. For more information, see USCS technical notes (https://www.cdc.gov/cancer/npcr/uscs/pdf/uscs-2013-technical-notes.pdf#nameddest=RegistriesPubCriteria).

† Invasive cancer excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in situ cancers except urinary bladder.

§ Data are compiled from cancer registries that meet the data quality criteria for all invasive cancer sites combined (all registries except Nevada, covering approximately 99% of the U.S. population).

Return to your place in the textFIGURE 4. Age-adjusted rate* of cancer deaths, by primary cancer site and state — United States, 2013†

* Rates are the number of deaths per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups – Census P25–1130). Rates are presented by quartiles. For more information, see USCS technical notes (https://www.cdc.gov/cancer/npcr/uscs/pdf/uscs-2013-technical-notes.pdf#nameddest=RegistriesPubCriteria).

† Data are from the National Vital Statistics System (NVSS). Data for death rates cover 100% of the U.S. population. Caution should be used when comparing incidence and death rates because of potential differences in population coverage.

Return to your place in the textTABLE 11. Reported number of invasive* cancer cases, all cancer sites combined, by state — United States, 2004–2013†
State 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013
Alaska 2,430 2,371 2,496 2,513 2,671 2,647 2,746 2,666 2,612 2,664
Alabama 22,251 22,665 23,351 24,215 25,316 25,307 25,305 25,195 25,383 25,340
Arkansas 13,918 14,203 14,417 14,871 14,833 14,984 15,190 15,151 15,512 15,879
Arizona 24,196 24,629 25,784 27,018 26,803 28,295 27,622 28,743 28,545 28,418
California 146,314 148,143 149,651 156,072 158,341 160,282 161,351 161,217 160,817 160,911
Colorado 18,345 18,882 19,261 20,696 20,948 21,627 21,448 21,761 21,846 21,764
Connecticut 19,474 19,775 20,534 20,587 20,692 21,069 20,773 20,665 20,592 20,510
District of Columbia 2,742 2,765 2,751 2,972 2,728 2,807 2,939 3,135 3,003 2,780
Delaware 4,495 4,799 5,058 5,141 5,239 5,277 5,281 5,466 5,459 5,681
Florida 101,494 104,701 105,486 107,733 110,183 109,603 108,931 110,653 109,554 108,216
Georgia 36,724 37,382 39,182 42,013 42,977 43,660 43,118 44,921 46,154 45,984
Hawaii 6,013 6,103 6,194 6,406 6,640 6,773 6,730 6,788 6,852 7,000
Idaho 6,170 6,573 6,766 7,171 7,148 7,366 7,431 7,551 7,538 7,358
Illinois 61,518 61,898 63,773 64,956 66,301 66,557 65,198 66,369 65,130 64,959
Indiana 30,156 30,659 31,712 32,023 32,417 32,423 32,677 32,864 32,543 32,372
Iowa 16,254 16,457 16,744 16,852 16,944 17,594 17,526 17,531 17,175 16,911
Kansas 13,644 13,695 14,003 14,553 14,727 14,608 14,608 14,906 14,843 14,572
Kentucky 22,498 22,774 23,960 24,527 24,697 24,919 25,484 25,669 26,191 26,068
Louisiana 22,071 21,076 21,575 22,431 22,906 23,560 23,661 24,150 24,198 24,184
Massachusetts 35,459 35,919 37,105 37,201 37,736 37,478 35,711 37,198 36,481 36,097
Maryland 25,491 25,865 26,002 27,907 28,447 28,463 28,710 28,642 28,489 29,824
Maine 8,347 8,305 8,628 8,542 8,472 8,356 8,385 8,336 8,481 8,366
Michigan 52,128 52,819 53,501 55,831 53,580 54,009 55,167 55,617 53,248 52,067
Minnesota 24,502 24,622 25,505 26,801 26,990 26,901 27,028 28,019 27,835 27,770
Missouri 28,895 30,601 30,832 31,108 31,042 31,893 31,203 31,901 32,136 31,628
Mississippi 13,506 13,663 14,235 15,005 15,328 15,033 15,460 15,361 15,343 15,482
Montana 4,914 5,225 5,192 5,350 5,369 5,612 5,627 5,722 5,517 5,610
North Carolina 41,513 43,778 44,991 46,870 47,706 49,465 49,546 50,395 49,248 49,970
North Dakota 3,327 3,477 3,497 3,594 3,525 3,485 3,585 3,724 3,694 3,508
Nebraska 8,807 9,031 9,171 9,398 9,216 8,851 9,158 9,204 9,018 9,176
Nevada —§ — — — — — — — — —
New Hampshire 7,002 7,233 7,280 7,448 7,714 7,618 7,742 7,971 7,745 7,886
New Jersey 46,552 46,971 48,590 49,194 49,083 49,495 48,838 49,687 49,268 49,960
New Mexico 8,247 8,272 8,486 8,775 8,984 9,021 9,006 8,851 8,815 8,728
New York 100,219 101,660 104,618 106,397 108,138 108,711 106,341 110,138 106,911 109,560
Ohio 58,765 60,115 60,763 61,490 63,211 62,975 61,175 62,348 60,801 62,802
Oklahoma 17,758 17,875 18,960 19,744 18,857 18,957 18,637 18,897 19,082 19,044
Oregon 18,499 18,682 19,112 19,376 20,370 19,909 19,727 20,636 20,035 20,458
Pennsylvania 73,045 73,803 75,923 77,186 77,243 77,601 77,931 79,562 76,689 77,562
Rhode Island 6,289 6,001 6,270 6,358 6,269 6,239 5,762 5,898 6,168 6,097
South Carolina 21,118 21,933 22,555 23,504 23,576 23,883 24,638 24,737 25,399 24,809
South Dakota 4,021 3,922 3,830 4,079 4,029 4,191 4,126 4,429 4,225 4,417
Tennessee 27,702 30,218 30,998 32,100 32,957 34,014 33,854 34,374 34,363 34,142
Texas 90,532 92,394 94,362 98,911 99,603 100,782 99,386 100,351 101,919 101,962
Utah 7,763 7,920 8,309 8,517 8,859 9,108 9,496 9,712 9,681 9,626
Virginia 33,484 34,571 35,351 37,244 37,308 37,846 36,402 37,277 36,744 38,151
Vermont 3,387 3,460 3,718 3,602 3,529 3,681 3,659 3,630 3,609 3,510
Washington 30,679 31,403 31,843 31,339 33,240 34,143 34,320 34,869 34,883 34,865
Wisconsin 27,929 27,869 28,645 29,475 29,967 30,174 30,575 31,413 30,572 30,638
West Virginia 10,741 11,071 11,250 11,546 11,296 11,352 11,231 11,638 11,336 11,327

*Invasive cancer excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in situ cancers except urinary bladder.
†Data are compiled from cancer registries that meet the data quality criteria for all invasive cancer sites combined (all registries except Nevada, covering approximately 99% of the U.S. population). Registry-specific data quality information is available at https://www.cdc.gov/cancer/npcr/uscs/pdf/uscs-2013-technical-notes.pdf#nameddest=RegistriesPubCriteria.
§Counts are not presented for Nevada because data from Nevada did not meet USCS publication criteria for all the years from 2004 to 2013.

Return to your place in the textTABLE 12. Reported rate* of invasive† cancer cases, all cancer sites combined, by state — United States, 2004–2013§
State 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013
Alaska 511.2 481.2 486.2 471.6 479.5 460.5 458.7 430.7 404.0 410.4
Alabama 460.6 461.7 464.7 473.4 485.0 477.2 466.6 457.7 453.8 444.0
Arkansas 462.1 465.1 461.3 468.4 457.6 455.2 453.5 445.0 450.1 454.0
Arizona 418.1 408.7 413.1 419.1 405.9 415.7 394.8 399.8 384.7 370.6
California 451.6 448.1 446.1 455.5 451.0 445.6 437.2 425.6 414.0 402.8
Colorado 447.1 447.1 439.7 456.9 447.0 445.2 429.4 423.1 409.8 396.1
Connecticut 507.5 510.0 524.5 518.6 511.4 514.1 499.7 490.4 482.3 474.2
District of Columbia 487.4 487.0 488.7 523.8 477.2 482.2 494.6 516.6 482.4 445.2
Delaware 507.7 525.8 537.5 529.1 526.3 516.6 507.6 511.8 496.7 502.0
Florida 470.9 474.1 469.7 470.9 471.9 460.6 447.8 444.3 428.5 413.0
Georgia 476.6 468.9 473.0 490.3 485.5 480.1 459.5 468.3 465.0 450.3
Hawaii 435.2 430.2 427.4 434.2 438.7 438.9 425.6 421.8 418.1 419.8
Idaho 463.1 478.0 473.0 484.4 467.3 467.6 458.0 454.4 442.2 419.5
Illinois 492.8 490.0 500.1 501.6 503.5 497.8 479.9 480.8 463.8 454.9
Indiana 476.4 477.3 485.4 481.5 477.4 469.5 465.4 460.3 448.8 438.8
Iowa 485.3 487.6 490.4 487.7 485.1 497.0 489.5 484.4 468.0 456.1
Kansas 481.1 477.7 481.9 493.6 492.0 479.4 473.5 477.6 467.4 450.9
Kentucky 521.9 518.1 533.8 535.1 528.3 523.3 526.4 521.6 522.1 511.7
Louisiana 497.0 481.1 493.8 501.1 500.3 502.0 495.4 494.5 485.8 476.3
Massachusetts 514.3 517.0 529.8 523.3 522.0 509.5 477.9 489.3 471.9 457.5
Maryland 463.9 463.1 458.1 482.3 482.3 469.1 465.4 452.3 440.2 451.0
Maine 544.7 534.0 544.8 527.8 512.8 499.1 493.4 484.0 478.7 463.8
Michigan 504.2 504.5 504.2 517.1 489.8 485.8 489.1 485.1 456.8 440.1
Minnesota 481.2 475.7 483.3 496.5 488.5 476.9 471.3 477.7 462.8 451.8
Missouri 470.3 490.5 485.7 481.5 471.8 476.2 458.4 462.2 457.6 442.6
Mississippi 468.1 469.2 479.5 495.1 498.4 482.2 485.8 474.6 465.3 459.9
Montana 473.6 492.2 478.2 475.6 467.3 476.9 472.2 468.8 442.1 437.0
North Carolina 478.1 490.3 486.6 490.2 483.8 489.3 477.6 473.3 450.8 445.4
North Dakota 462.9 479.8 475.8 485.2 467.5 458.7 462.9 470.0 464.0 433.6
Nebraska 479.3 485.0 485.9 490.7 473.6 449.0 456.4 453.8 435.7 437.6
Nevada — — — — — — — — — —
New Hampshire 523.9 530.6 519.3 517.8 524.6 506.3 502.0 510.8 484.6 479.2
New Jersey 508.9 509.4 522.0 521.7 512.8 509.6 494.6 496.9 484.4 483.1
New Mexico 431.0 420.4 416.5 419.0 418.8 409.4 397.0 381.7 374.7 363.7
New York 496.2 499.5 511.0 513.1 514.8 510.0 492.1 501.2 479.8 484.3
Ohio 479.4 485.3 484.3 482.5 488.6 480.8 459.7 463.0 444.8 452.4
Oklahoma 477.6 475.0 494.7 505.9 474.8 467.8 452.4 451.5 449.5 440.3
Oregon 484.8 477.6 475.0 470.6 482.3 461.5 447.5 458.1 432.5 431.5
Pennsylvania 502.5 503.9 512.8 515.2 509.9 506.8 502.8 507.5 482.9 483.0
Rhode Island 530.8 508.5 526.6 532.4 519.1 512.6 468.7 476.6 488.9 479.4
South Carolina 484.2 490.4 485.8 489.0 475.0 469.2 472.1 463.4 459.8 436.9
South Dakota 476.5 459.9 440.3 460.9 448.2 459.6 443.2 467.5 439.6 450.1
Tennessee 449.7 479.2 478.8 483.3 484.0 489.9 476.6 472.9 463.6 450.9
Texas 467.9 464.3 457.7 465.3 454.4 445.8 427.3 417.6 411.5 399.4
Utah 426.4 419.7 423.4 419.2 421.7 419.9 424.5 422.9 408.4 393.2
Virginia 455.7 458.8 458.9 471.4 462.0 457.4 428.8 429.3 414.0 418.5
Vermont 499.5 501.2 529.0 501.3 479.1 492.8 481.0 469.9 457.0 437.1
Washington 505.3 504.3 496.9 475.4 491.6 490.1 479.6 476.3 463.3 450.3
Wisconsin 480.8 472.5 478.5 483.4 482.4 477.8 476.5 479.3 457.7 451.1
West Virginia 491.8 501.2 503.1 507.9 491.5 488.1 477.7 489.7 470.7 464.0
Wyoming 451.2 427.5 454.2 436.1 438.1 426.5 432.9 437.2 398.0 382.0

*Rates are the number of cases per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups – Census P25–1130). For more information, see USCS technical notes (https://www.cdc.gov/cancer/npcr/uscs/pdf/uscs-2013-technical-notes.pdf).
†Invasive cancer excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in situ cancers except urinary bladder.
§Data are compiled from cancer registries that meet the data quality criteria for all invasive cancer sites combined (all registries except Nevada, covering approximately 99% of the U.S. population). Registry-specific data quality information is available at https://www.cdc.gov/cancer/npcr/uscs/pdf/uscs-2013-technical-notes.pdf#nameddest=RegistriesPubCriteria.
Rates are not presented for Nevada because data from Nevada did not meet USCS publication criteria for all the years from 2004 to 2013.

Return to your place in the textFIGURE 5. Age-adjusted rate* of invasive† cancer cases, by primary cancer site, race,§ and sex — United States, 1999–2013

Abbreviations: AI/AN = American Indian/Alaska Native; A/PI = Asian/Pacific Islander.

* Rates are the number of cases per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups – Census P25–1130). For more information, see USCS technical notes (https://www.cdc.gov/cancer/npcr/uscs/pdf/uscs-2013-technical-notes.pdf).

† Invasive cancer excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in situ cancers except urinary bladder.

§ Rates are not presented for persons of unknown or other race. Data for specified racial populations other than white and black should be interpreted with caution. For more information, see USCS technical notes (https://www.cdc.gov/cancer/npcr/uscs/pdf/uscs-2013-technical-notes.pdf#nameddest=IntRaceEthnicityData).

Data are compiled from cancer registries that meet the data quality criteria for all invasive cancer sites combined for all years, 1999–2013 (all registries except Arkansas, District of Columbia, Mississippi, Nevada, South Dakota, Tennessee, and Virginia, covering approximately 92% of the U.S. population). See registry-specific data quality information for all years, 1999–2013 (https://www.cdc.gov/cancer/npcr/uscs/pdf/uscs-2013-technical-notes.pdf#nameddest=RegistriesPubCriteria). Caution should be used when comparing incidence and death rates because of potential differences in population coverage.

Return to your place in the textFIGURE 6. Age-adjusted rate* of invasive† cancer cases, by primary cancer site, ethnicity,§ and sex — United States, 1999–2013

* Rates are the number of cases per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups – Census P25–1130). For more information, see USCS technical notes(https://www.cdc.gov/cancer/npcr/uscs/pdf/uscs-2013-technical-notes.pdf).

† Invasive cancer excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in situ cancers except urinary bladder.

§ Rates are not presented for persons of unknown ethnicity. Data for specified ethnical populations should be interpreted with caution. For more information, see USCS technical notes (https://www.cdc.gov/cancer/npcr/uscs/pdf/uscs-2013-technical-notes.pdf#nameddest=IntRaceEthnicityData).

Data are compiled from cancer registries that meet the data quality criteria for all invasive cancer sites combined for all years, 1999–2013 (all registries except Arkansas, District of Columbia, Mississippi, Nevada, South Dakota, Tennessee, and Virginia, covering approximately 92% of the U.S. population). See registry-specific data quality information for all years, 1999–2013 (https://www.cdc.gov/cancer/npcr/uscs/pdf/uscs-2013-technical-notes.pdf#nameddest=RegistriesPubCriteria). Caution should be used when comparing incidence and death rates because of potential differences in population coverage.

Return to your place in the textFIGURE 7. Age-adjusted rate* of cancer deaths, by primary cancer site, race,† and sex — United States, 2013§

Abbreviations: AI/AN = American Indian/Alaska Native; A/PI = Asian/Pacific Islander.

* Rates are the number of deaths per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups – Census P25–1130). For more information, see USCS technical notes (https://www.cdc.gov/cancer/npcr/uscs/pdf/uscs-2013-technical-notes.pdf).

† Rates are not presented for persons of unknown or other race. Data for specified racial populations other than white and black should be interpreted with caution. For more information, see USCS technical notes (https://www.cdc.gov/cancer/npcr/uscs/pdf/uscs-2013-technical-notes.pdf#nameddest=IntRaceEthnicityData).

§ Data are from the National Vital Statistics System (NVSS). Data for death rates cover 100% of the U.S. population. Use caution when comparing incidence and death rates because of potential differences in population coverage.

Return to your place in the textFIGURE 8. Reported rate* of cancer deaths, by primary cancer site, ethnicity,† and sex — United States, 2013§

* Rates are the number of deaths per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups – Census P25–1130). For more information, see USCS technical notes (https://www.cdc.gov/cancer/npcr/uscs/pdf/uscs-2013-technical-notes.pdf).

† Rates are not presented for persons of unknown ethnicity. Data for specified ethnic populations should be interpreted with caution. For more information, see USCS technical notes (https://www.cdc.gov/cancer/npcr/uscs/pdf/uscs-2013-technical-notes.pdf#nameddest=IntRaceEthnicityData).

§ Data are from the National Vital Statistics System (NVSS). Data for death rates cover 100% of the U.S. population. Use caution when comparing incidence and death rates because of potential differences in population coverage.

Return to your place in the textTABLE 13. Reported number of cancer deaths, all cancer sites combined, by state — United States, 2004–2013*
State 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013
Alabama 9,756 9,913 9,899 10,025 10,182 10,289 10,196 10,233 10,274 10,328
Alaska 728 732 790 839 867 895 884 935 925 1,016
Arizona 9,618 9,820 9,918 10,133 10,081 10,271 10,678 10,690 11,085 11,347
Arkansas 6,304 6,361 6,177 6,388 6,526 6,513 6,475 6,497 6,540 6,688
California 53,700 54,729 54,140 55,011 54,686 55,990 56,453 56,448 57,675 57,714
Colorado 6,196 6,395 6,550 6,617 6,719 6,950 7,035 7,051 7,306 7,357
Connecticut 7,174 7,052 7,044 6,827 6,830 6,819 6,954 6,837 6,681 6,619
Delaware 1,827 1,799 1,780 1,852 1,912 1,813 1,909 1,905 1,935 1,905
District of Columbia 1,152 1,150 1,178 1,169 1,143 1,131 1,041 1,070 1,081 1,095
Florida 39,840 40,592 40,415 40,088 40,814 40,931 41,467 41,681 42,187 42,734
Georgia 14,313 14,358 14,474 14,983 14,621 15,139 15,435 15,602 16,020 16,417
Hawaii 2,088 2,169 2,171 2,214 2,194 2,244 2,266 2,278 2,284 2,332
Idaho 2,227 2,368 2,306 2,405 2,511 2,458 2,530 2,573 2,572 2,707
Illinois 24,289 24,250 24,083 24,113 24,298 24,182 24,070 24,006 24,562 24,491
Indiana 12,552 12,796 12,903 12,778 13,136 13,093 13,164 13,180 13,368 13,258
Iowa 6,340 6,453 6,359 6,376 6,424 6,249 6,358 6,481 6,438 6,509
Kansas 5,312 5,428 5,343 5,406 5,294 5,319 5,377 5,440 5,429 5,379
Kentucky 9,159 9,505 9,394 9,692 9,589 9,634 9,930 9,733 10,012 10,082
Louisiana 9,434 9,249 8,853 8,736 9,197 9,098 9,203 9,233 9,308 9,419
Maine 3,124 3,218 3,089 3,112 3,093 3,133 3,247 3,201 3,226 3,227
Maryland 10,168 10,371 10,350 10,179 10,360 10,412 10,268 10,249 10,524 10,608
Massachusetts 13,337 13,182 13,407 13,003 13,031 13,112 12,993 12,895 12,864 12,858
Michigan 19,653 20,094 20,192 20,087 20,211 20,257 20,620 20,420 20,496 20,367
Minnesota 9,093 8,823 9,079 9,176 9,446 9,580 9,612 9,489 9,424 9,601
Mississippi 5,983 6,065 6,236 6,001 6,165 6,130 6,271 6,278 6,496 6,527
Missouri 12,449 12,417 12,519 12,380 12,522 12,472 12,626 12,473 12,919 12,955
Montana 1,867 1,956 1,943 1,921 1,862 1,914 1,923 2,022 1,954 1,997
Nebraska 3,270 3,355 3,430 3,479 3,376 3,336 3,438 3,410 3,479 3,459
Nevada 4,119 4,238 4,225 4,331 4,404 4,461 4,529 4,605 4,610 4,817
New Hampshire 2,554 2,549 2,534 2,609 2,576 2,562 2,525 2,740 2,660 2,584
New Jersey 17,206 17,171 17,180 17,096 16,874 16,540 16,815 16,708 16,483 16,315
New Mexico 3,035 3,141 3,147 3,236 3,355 3,202 3,358 3,328 3,461 3,481
New York 36,100 35,555 35,283 35,485 35,351 35,215 35,431 35,469 35,881 35,735
North Carolina 16,477 16,724 17,318 17,478 17,453 17,513 18,060 18,284 18,405 18,589
North Dakota 1,265 1,302 1,387 1,264 1,354 1,243 1,269 1,321 1,253 1,286
Ohio 24,940 24,702 24,975 25,230 24,998 25,149 25,083 25,140 25,261 24,986
Oklahoma 7,269 7,446 7,491 7,727 7,657 7,639 7,831 7,997 8,040 8,039
Oregon 7,236 7,326 7,309 7,393 7,479 7,487 7,638 7,802 7,832 7,799
Pennsylvania 29,422 29,615 29,170 29,013 28,963 28,879 29,055 28,895 28,907 28,512
Rhode Island 2,418 2,291 2,250 2,213 2,227 2,220 2,266 2,170 2,148 2,326
South Carolina 8,348 8,652 8,853 8,867 9,199 9,123 9,356 9,543 9,728 9,745
South Dakota 1,555 1,612 1,570 1,612 1,570 1,503 1,655 1,665 1,630 1,577
Tennessee 12,586 12,995 13,051 13,161 13,162 13,482 13,593 13,562 13,765 13,953
Texas 33,937 34,291 34,938 35,074 35,712 35,591 36,717 37,351 38,142 38,412
Utah 2,445 2,520 2,615 2,572 2,492 2,555 2,810 2,746 2,876 2,971
Vermont 1,212 1,202 1,214 1,346 1,279 1,254 1,392 1,347 1,325 1,318
Virginia 13,384 13,877 13,828 14,009 13,983 14,122 14,078 14,374 14,294 14,414
Washington 10,989 11,048 11,055 11,568 11,618 11,922 11,874 12,002 11,951 11,928
West Virginia 4,694 4,617 4,613 4,690 4,605 4,786 4,685 4,782 4,684 4,718
Wisconsin 10,861 10,943 10,925 10,963 11,185 10,866 11,279 11,608 11,252 11,425
Wyoming 875 886 927 940 874 936 1,016 936 955 946

*Data are from the National Vital Statistics System (NVSS).

Return to your place in the textTABLE 14. Reported rate* of cancer deaths, all cancer sites combined, by state — United States, 2004–2013†
State 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013
Alabama 204.6 204.7 199.8 198.5 197.3 196.3 190.7 187.4 184.8 182.1
Alaska 185.9 173.3 179.7 185.2 183.2 186.5 178.4 176.4 169.1 173.1
Arizona 167.4 164.2 160.0 158.8 153.2 152.0 152.6 148.3 148.1 146.4
Arkansas 208.3 207.5 196.6 201.0 201.1 198.0 193.7 191.2 188.6 189.6
California 169.4 169.2 164.8 163.9 158.9 158.8 155.8 151.8 150.7 146.6
Colorado 159.9 160.5 158.4 154.7 151.2 151.9 148.8 144.2 143.7 139.2
Connecticut 182.0 176.7 175.3 167.0 164.7 162.8 162.4 158.1 152.0 147.8
Delaware 208.0 199.1 190.6 193.3 192.7 178.0 184.4 179.8 176.2 167.1
District of Columbia 206.2 206.2 210.8 208.8 201.8 196.9 178.4 180.8 178.4 177.7
Florida 178.9 177.9 174.2 169.3 168.8 165.9 163.8 160.0 157.6 154.9
Georgia 196.3 190.8 184.9 186.1 175.7 176.3 173.9 171.0 169.6 168.1
Hawaii 150.2 151.4 148.2 147.5 142.0 141.3 140.5 138.6 134.4 134.9
Idaho 169.8 174.7 163.6 166.5 166.9 159.0 158.6 157.7 152.2 156.3
Illinois 194.9 192.4 188.9 186.6 185.0 181.7 177.9 174.7 175.4 171.7
Indiana 199.2 200.0 198.0 192.9 194.4 190.4 187.6 185.2 184.2 179.4
Iowa 181.8 183.1 178.6 176.5 176.4 169.6 170.7 172.4 167.9 168.2
Kansas 182.8 185.5 180.0 178.6 173.1 171.5 170.4 170.1 167.7 162.9
Kentucky 215.8 219.5 212.5 215.0 208.0 204.8 207.4 200.9 201.2 199.3
Louisiana 216.6 215.4 206.9 199.2 205.8 198.6 196.4 193.5 190.4 188.7
Maine 202.1 204.8 192.8 189.8 184.6 185.4 186.6 181.7 179.0 174.8
Maryland 190.9 190.7 187.4 180.9 180.6 176.7 170.2 166.0 165.9 163.0
Massachusetts 189.8 186.0 187.3 179.2 176.9 175.3 170.0 166.7 163.3 159.7
Michigan 191.1 192.7 190.8 186.4 184.5 182.0 182.0 177.4 174.3 170.2
Minnesota 176.8 169.1 171.0 168.4 170.3 168.7 166.1 160.5 155.6 155.1
Mississippi 210.2 211.3 213.2 201.9 202.8 199.7 200.4 196.7 200.0 196.5
Missouri 201.0 197.9 195.9 190.9 189.5 185.4 184.7 179.4 182.0 179.1
Montana 179.2 184.3 177.9 170.9 161.2 162.8 159.9 164.6 154.2 154.0
Nebraska 173.6 175.1 176.7 176.3 169.9 164.7 166.6 164.3 164.7 160.7
Nevada 192.5 191.7 185.5 181.3 179.8 175.6 173.5 170.3 163.7 164.9
New Hampshire 195.5 189.9 184.3 185.1 177.6 173.3 167.7 177.9 167.9 158.6
New Jersey 186.9 185.0 183.2 179.8 175.0 168.8 168.7 165.7 160.1 156.0
New Mexico 162.5 163.1 158.8 158.3 160.7 149.0 151.3 146.7 147.8 145.1
New York 177.7 173.5 171.1 169.7 166.6 163.9 162.1 159.6 159.4 155.5
North Carolina 194.0 191.6 191.8 187.3 181.3 177.0 177.9 174.8 170.4 167.7
North Dakota 166.2 169.9 179.8 162.3 171.2 155.6 156.1 160.4 150.6 150.8
Ohio 202.1 198.1 197.5 196.3 191.6 190.1 186.6 184.5 182.1 177.4
Oklahoma 196.0 198.0 195.3 198.5 193.0 189.3 190.4 191.2 189.4 185.4
Oregon 188.8 186.8 181.4 178.7 176.8 172.5 172.8 172.4 168.2 163.2
Pennsylvania 195.7 195.2 190.3 186.4 184.1 181.7 180.5 177.4 174.8 170.0
Rhode Island 196.4 186.5 181.8 177.8 177.5 173.7 176.7 168.5 163.3 173.9
South Carolina 195.9 198.3 195.0 188.4 190.3 182.8 182.6 182.3 179.1 174.0
South Dakota 177.3 181.7 172.7 174.1 167.9 158.4 169.8 168.6 162.1 154.1
Tennessee 208.4 210.6 205.0 201.6 197.1 197.7 194.6 189.1 187.8 185.4
Texas 182.6 179.5 176.7 172.3 170.4 164.8 165.1 162.5 160.3 156.9
Utah 141.0 141.0 140.2 133.6 125.8 124.9 133.0 125.6 128.8 127.9
Vermont 180.1 176.1 173.2 188.7 176.2 169.2 182.6 175.9 164.7 164.1
Virginia 189.0 190.6 185.8 184.1 179.4 176.4 171.7 170.8 165.2 162.3
Washington 184.9 181.4 175.9 179.4 175.9 175.1 169.7 166.9 161.8 156.3
West Virginia 212.3 207.6 204.0 204.3 197.9 203.3 196.6 199.7 191.1 190.5
Wisconsin 184.6 182.9 180.1 177.3 177.8 169.5 173.8 174.8 166.0 164.6
Wyoming 172.1 169.3 174.5 173.4 157.0 163.8 170.1 155.9 154.2 147.7

*Rates are the number of deaths per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups – Census P25–1130). For more information, see USCS technical notes (https://www.cdc.gov/cancer/npcr/uscs/pdf/uscs-2013-technical-notes.pdf).
†Data are from the National Vital Statistics System (NVSS).

Suggested citation for this article: Singh SD, Henley SJ, Ryerson AB. Surveillance for Cancer Incidence and Mortality — United States, 2013. MMWR Surveill Summ 2017;66(No. SS-4):1–36. DOI: http://dx.doi.org/10.15585/mmwr.ss6604a1.

Use of trade names and commercial sources is for identification only and does not imply endorsement by the U.S. Department of Health and Human Services.
References to non-CDC sites on the Internet are provided as a service to MMWR readers and do not constitute or imply endorsement of these organizations or their programs by CDC or the U.S. Department of Health and Human Services. CDC is not responsible for the content of pages found at these sites. URL addresses listed in MMWR were current as of the date of publication.

All HTML versions of MMWR articles are generated from final proofs through an automated process. This conversion might result in character translation or format errors in the HTML version. Users are referred to the electronic PDF version (https://www.cdc.gov/mmwr) and/or the original MMWR paper copy for printable versions of official text, figures, and tables.

Questions or messages regarding errors in formatting should be addressed to mmwrq@cdc.gov.

Format:
TOP
window.CDC.Policy.External.init();